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Abstract
This dissertation focuses on approaches which integrate both gene-expression data
and genetic association results to extend insight into disease pathogenesis. We in-
vestigate and proffer strategies to accurately estimate cell type composition using
both single cell and single nucleus RNA-Seq data in Brain (Chapter 2). We map cis
regulatory effects in the retinal transcriptome and integrate data about trait asso-
ciated variants to identify potential target genes which are involved in Age-related
Macular Degeneration (Chapter 3). We propose a likelihood framework to model
trans-regulatory effect size distribution and apply the method to four tissues, using
summary level data, from the Genotype-Tissue Expression Consortium (Chapter 4).
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Chapter 1
Introduction
Interest in the post-GWAS era has moved from discovery to gaining mechanistic
insights about trait-associated variants. Since most associations lie in non-coding
regions of the genome, hence are likely involved in the disease/trait process through
gene regulation, attention has been placed on the integration of RNA-seq data with
GWAs results. To identify variants involved in gene regulation, both cis (local) and
trans(distal) regulatory effects of these variants on gene expression are been studied
across diverse tissues[1, 2, 3, 4, 5, 6] with both approaches having varying degrees of
success. Analyses concerning cis-regulation, in particular, have been more successful
relative to trans-regulation, with cis-regulation being shown to be more tissue agnos-
tic, have larger effects, and have been helpful in identifying likely causal genes that are
involved in the disease process[2, 3, 7, 8]. In contrast, results from trans-regulation
have been sparse, mostly because of their much smaller effect sizes. Despite this,
current findings show that trans-regulatory effects are more tissue-dependent, thus
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providing valuable insights about tissue-specific mechanisms in the disease pathogen-
esis. Furthermore, trans-effects have also be shown to extend insights for loci with
multiple cis effects, used to reveal novel pathways for a given phenotype and identify
relationships between trait-associated SNPs that are independent[2, 3].
This dissertation focuses on approaches that integrate both gene-expression and
genotype data to provide mechanistic insights for genetic associations by means of
gene-expression regulation. Gene expression levels are affected by both environmen-
tal and genetic effects. For instance, we know that expression levels can vary signif-
icantly between different tissues[1, 2], cell types[9, 10, 11], and even over time[12].
Furthermore, multiple studies[2, 3] have shown that gene regulatory effects can vary
by cell type. These variations can be used to identify cis-regulatory effects, and
aid in interpreting regulatory variants underlying complex disease risk. However,
genomic profiles corresponding to these cell types are often unobserved since bulk
RNA-Seq is generated based on tissues which consist of mixtures of cell types (i..e.,
cellular composition). Hence, multiple approaches have been developed to estimate
(or deconvolve) the relative or absolute amounts of each cell type in a given tissue.
In Chapter 1 we focus on such approaches and show that several existing deconvolu-
tion algorithms which estimate the RNA composition of homogenate tissue, relates
to the amount of RNA attributable to each cell type, and not the cellular composi-
tion (absolute estimates) relating to the underlying fraction of cells. We show that
incorporating ”cell size” parameters into RNA-based deconvolution algorithms can
successfully recover cellular fractions in homogenate brain RNA-seq data. Further-
more, we show that using both cell sizes and cell type-specific gene expression profiles
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from brain regions other than the target/user-provided bulk tissue RNA-seq dataset
consistently results in biased cell fractions.
In Chapter 2, we integrate data from retinal transcriptomes, covering 13,662
protein-coding and 1,462 non-coding genes, with genotypes at over 9 million common
single nucleotide polymorphisms (SNPs) for expression quantitative trait loci (eQTL)
analysis of a tissue not included in Genotype-Tissue Expression (GTEx) and other
large datasets[13, 1, 2]. Furthermore, by combining findings from transcriptome-
wide association analysis (TWAS), colocalization analysis, cis-eQTL analysis, and
AMD GWAS we able to extend insights for trait-associated variants. In Chapter
3, we propose a likelihood framework, using summary level, to estimate both the
heritability and polygenicity (the number of loci that contribute to heritability) of
trans-regulatory effects. We circumvent issues related to small sample sizes that
are seen in current studies involving trans-eQTLs by marginalizing across genes and
have developed a computationally efficient approach to summarize the data. Hence,
dealing with the large number of marginal effects typically encountered in trans-
eQTL analyses. Subsequently, we applied our model, using summary level data, to
four tissues from GTEx V8.
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Chapter 2
Strategies for cellular
deconvolution in human brain
RNA sequencing data
2.1 Introduction
Homogenate tissues like brain and blood contain a mixture of cell types which can
each have unique genomic profiles, and these mixtures of cell types, termed ”cellular
composition”, can vary across samples[14]. The importance of considering cellular
composition within heterogeneous tissue sources has been highlighted in epigenetics
research over the past several years[14, 15, 16], as, generally, failure to account for
cellular composition when analyzing heterogeneous tissue sources can increase both
false positives and negatives[17]. Previous work has identified widespread epigenetic
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differences between neurons and glia using DNA methylation (DNAm) data[16, 18],
and false positives may arise when there are cellular composition differences associ-
ated with dissection variability, disease, normal development or any other outcome of
interest. For example, loss of neurons (or glia) because of disease may cause spurious
loci associations with illness that stem solely from differing cellular compositions be-
tween disease states, or cell-type specific biological differences may exist that become
more difficult to detect in the presence of unaffected cell types.
Statistical algorithms estimate the relative or absolute amounts of each cell type
in the homogenate tissue data. These so called ”cellular deconvolution” algorithms
have been especially popular using DNAm data[19] as DNAm levels are constrained
between 0 and 1 and are binary within single cells (i.e., individual CpGs are either
methylated or unmethylated). These deconvolution algorithms can be classified into
two general types, termed ”referenced-based” and ”reference-free”[19, 20]. Reference-
free approaches only require as input an estimate of the number of potential cell types
in a particular dataset (which can be non-trivial), and return latent components that
preferentially capture cellular heterogeneity that can be adjusted for in differential
methylation analysis[14, 19, 21]. However, these approaches do not return fractions
of cells and may capture potential batch effects in addition to cellular composition.
Conversely, reference-based approaches require cell type-specific genomic profiles for
each cell type of interest as an input and return the relative fraction of each input
cell type for each queried bulk sample[15], akin to an in silico cell counter. This
class of algorithms therefore requires the generation of potentially many pure cell
populations, which are typically generated from flow cytometry for applications to
5
DNAm data from bulk tissue.
While DNAm data can generate accurate absolute cell fractions in homogenate
brain tissue[16, 18, 22] , there are several important considerations limiting more
widespread application. First, RNA and gene expression profiling has been much
more popular in postmortem brain studies, with more samples profiled with RNA
sequencing (RNA-seq) than DNAm microarrays or sequencing. Secondly, the two
cell classes typically used by DNAm-deconvolution algorithms are likely too broad
to identify more subtle differences in dissection variability and potential stereological
differences[23, 24]. While recent work has extended the number of cell populations
that can be isolated by antibodies to separate neurons into their excitatory and
inhibitory subclasses and oligodendrocytes from other glia[25], there are likely very
few additional cell types that are possible to isolate using nuclear antibodies for
DNAm samples. Researchers have therefore turned to using cell type-specific RNA
microarray and sequencing datasets to adapt these reference-based deconvolution
algorithms to homogenate RNA-seq samples[10, 11, 20, 26, 27, 28, 29, 30, 31, 32, 33,
34]. The majority of these studies have focused on tissues other than the brain, which
can be freshly obtained and dissociated into individual cells for single cell RNA-
seq (scRNA-seq) or be sorted into specific cell populations using flow cytometry
for cell type-specific expression profiling. For example, the popular CIBERSORT
approach[11] was designed for blood gene expression microarray data, but has been
adapted to RNA-seq datasets in other tissues. Several of the above algorithms have
been designed, adapted or implemented for brain tissue, including linear regression
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followed by quadratic programming using the Houseman algorithm[15, 33, 34], non-
negative least squares[32], the support vector machine-based CIBERSORT[11], the
empirical Bayes method MIND[30], and MuSiC, which combines a recursive tree
based approach with weighted non-negative least squares for cell type proportion
estimation[26].
However, few of these approaches have validated that the resulting composition
estimates are accurate, i.e, are absolutely similar to the true underlying composi-
tion, particularly in brain tissue. No approach to our knowledge has quantified the
consequences of parameter and algorithm choices when only non-ideal reference data
is available (e.g., mismatched tissue type, species, sequencing protocol, etc.), which
occurs in almost all applications. Many reference datasets have been constructed
from purified cell type-specific RNA-seq data from mouse[35], or RNA-seq data from
sorted or dissociated nuclei in humans[36, 37, 38, 39, 40], and not whole cells, which
are typically profiled in homogenate sequencing studies. Gene expression levels are
also quantitative within individual cells (and not binary like in DNAm data) and the
necessity of absolute expression levels for absolute composition quantification has
largely been overlooked.
Here we directly evaluated the absolute accuracy of several popular RNA-seq-
based deconvolution strategies using several different reference datasets including a
bulk/homogenate dataset with paired DNAm and RNA-seq data from the nucleus
accumbens (NAc) from 200+ deceased individuals[41]. We used the DNAm data to
estimate absolute neuronal fractions for each sample, and evaluated absolute RNA-
based deconvolution accuracy across a variety of scenarios. We first evaluated the
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effects of using deep single cell RNA-seq (scRNA-seq) from healthy fresh human
tissue obtained from surgically resected temporal cortex [9]. This dataset likely pro-
duces the most comparable RNA-seq profiles to frozen bulk postmortem tissue, since
whole cells were profiled, and 90% of RNA is cytosolic in the cortex[42]. However, this
dataset was derived from cells in a cortical brain region. We next produced snRNA-
seq data from postmortem human NAc to use as a reference dataset, which results
in potentially less comparable nuclear reference profiles but comes from a more com-
parable brain region. We lastly used cyclic-ouroboros single-molecule fluorescence
in situ hybridization (osmFISH) imaging data from the somatosensory cortex region
in mouse [43] to derive important parameters in popular deconvolution algorithms.
Together, our results demonstrate that many algorithms are not accurate, even when
estimating only two cell classes (neurons and glia), and we offer several strategies to
assess and improve accuracy that can be applied across multiple datasets and cell
types.
2.2 Methods
2.2.1 Estimation procedures
HOUSEMAN. This algorithm (Houseman et al., 2012) uses a linearly constrained
quadratic optimization approach with additional non-negative constraints on the
parameters. The linear constraint does not require that the sum of all coefficients
equal one. This allows the possibility of unknown cell types in case the specification is
not comprehensive. It was implemented using the minfi R Bioconductor package[44].
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MuSiC. The MuSiC (Wang et al., 2019) approach models the relationship between
the relative abundance of gene g in the bulk RNA-seq data and the mean expression
level of the same gene in the reference dataset for a given individual. The relationship
is provided below
Yg ∝
K∑
k=1
pkSkθkg
Where k = 1, . . . , K is the index of the cell types, pk is the proportion of cells from
cell type k, and θkg is the relative abundance for the g
th gene with respect to the
kth cell type. Sk is the cell size parameter and is defined as the average number of
total mRNA molecules for cell type k. By default, Sk is estimated automatically by
MuSiC. For the deconvolution method comparisons that assessed cell size impact on
neuronal cell type proportion estimation, Sk was derived from one of multiple data
sources (Table 2.1) using 1) default settings 2) osmFISH or 3) the average number of
total mRNA molecules for cell type k using only the top 25 or 50 most discriminating
genes per cell type. We defined ”most discriminating” as genes with the smallest
p-values and fold change > 0.25, relative to other cell types. All estimation was
carried out using the MuSiC package in R.
CIBERSORT. CIBERSORT uses a machine learning approach called ν-support
vector regression (Newman et al., 2015; Schlkopf et al., 2000) and requires at least 2
input datasets to work. The first is a signature matrix that identifies the set of genes
that are informative for the deconvolution procedure. The second is a bulk RNA-seq
dataset to estimate cell type proportions.
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The signature matrix depends on the tissue of interest. We generated a cus-
tom signature matrix. Using the Darmanis reference dataset, we generated both a
reference sample file (gene-by-cell matrix) and a phenotype classes file (cell type-by-
dummy variable identifying the cell type for each cell) and used the default setting
(https://cibersort.stanford.edu/) to obtain a custom signature gene expression ma-
trix. The specified false discovery rate (FDR) threshold used to include genes in
the signature matrix was 0.30 (i.e. q = 0.30, default). Using this signature matrix,
we then performed deconvolution on our bulk NAc RNA-seq data. As suggested in
the documentation for CIBERSORT (https://cibersort.stanford.edu/), we disabled
quantile normalization for our RNA-seq data.
NNLS/MIND. This is a simple linear regression with non-negativity constraints
on the parameter estimates. The estimated fractions are then the value of each pa-
rameter estimate divided by the sum of all parameter estimates across cell types.
MIND (https://github.com/randel/MIND) uses NNLS to estimate cell type frac-
tions.
2.2.2 Bulk NAc Data Generation and Processing
Data generation and processing were described extensively in Markunas et al. 2019[41]
and in Appendix A.
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2.2.3 Reference Datasets
Darmanis (Darmanis et al., 2015). scRNA-seq data for 58,037 genes and 556
cells were obtained for brain samples across 8 individuals, as described previously
(Darmanis et al., 2015). We filtered this dataset by removing cells based on em-
bryonic samples and retaining cells from one of the following five cell types; Neu-
ronal, Oligodendrocyte progenitor cells (OPC), Astrocytes, Oligodendrocytes, and
Microglia. We also removed genes that had no expression for all cells in the reference
dataset or did not show any expression in the bulk dataset (i.e., mean and variance
zero). In total, we used 265 cells for this reference and 24,048 genes to estimate the
cell type proportions for the 223 samples with bulk NAc data.
Single-nucleus RNA-seq data generation and processing in nucleus accum-
bens. Details are provided in Appendix A
2.3 Results
We motivate this work with a large human postmortem brain genomic dataset from
the NAc, a brain region containing functionally distinct cell types critical in reward-
processing and addiction[45, 46]. Genomic data from this region has been under-
represented in postmortem human brain sequencing studies, which have primarily
focused on the frontal cortex[32, 47, 48] but its underrepresentation allows us to more
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comprehensively evaluate the accuracy of cellular deconvolution using potentially im-
perfect and/or mismatched reference datasets (described below). We dissected ho-
mogenate NAc tissue from the ventral striatum (anterior to the optic chiasm) across
223 adult donors and concurrently extracted DNA and RNA from the exact same
tissue aliquot (see Methods), which allows for directly comparable cellular composi-
tion in each fraction. We profiled genome-wide DNAm with the Illumina Infinium
MethylationEPIC microarray and performed reference-based deconvolution to esti-
mate the fraction of neurons in each sample (see Methods). We have previously
demonstrated the absolute accuracy of the Houseman deconvolution algorithm[15]
in postmortem human brain DNAm data[18, 22]; here we found very high correlation
(ρ = -0.949, Figure A.1) between the neuronal fraction and the first principal compo-
nent (PC) of the entire DNAm profile (32.3% of variance explained), which we have
shown to be an accurate surrogate of composition in frontal cortex[49] and blood[14].
The corresponding RNA was sequenced using the Illumina sequencing with RiboZero
Gold library preparations (see Methods). This ”gold standard” dataset, therefore,
has DNAm-derived neuronal composition values and RNA-seq data from 223 sam-
ples to explore the accuracy and concordance of many popular cellular deconvolution
algorithms.
2.3.1 Mismatched reference datasets bias deconvolution
We first assessed the accuracy and concordance of four reference-based deconvolu-
tion algorithms: Houseman, CIBERSORT, NNLS/MIND, and MuSiC for two cell
populations - neurons and non-neurons/glia - in our NAc RNA-seq dataset using
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Fig. 2.1. Deconvolution in bulk NAc data using gene expression profiles from the
temporal cortex (Darmanis); Scatter plots showing the estimated neuronal proportions across
the 223 individuals using the Houseman approach for DNAm reference vs neuronal proportions
estimated using (a) the Houseman approach with scRNA reference, (b) MuSiC with default settings
and scRNA reference data, and (c) CIBERSORT with scRNA reference data.
recommended default settings (see Methods). We initially used single-cell RNA-seq
(scRNA-seq) data from the temporal cortex of eight adult donors obtained during
surgical resection generated and described in Darmanis et al., 2015[9] as the cell
type-specific reference profiles for these algorithms. Importantly, these reference
data were generated from fresh tissue, which preserved the integrity of the cells and
corresponding cytosolic RNA, the predominant fraction of total RNA from brain[42]
profiled in homogenate tissue. Furthermore, these reference profiles provide coverage
of entire transcripts (as opposed to only the 3′ ends) using Fluidigm C1 sequenc-
ing. Therefore, these expression profiles should be more comparable to bulk brain
sequencing studies, with the caveat that the reference dataset was obtained from
a different brain region (temporal cortex versus NAc and from living subjects as
opposed to postmortem subjects).
We used measures of root mean square error (RMSE) to assess accuracy and
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squared Pearson correlation coefficients (R2) to assess concordance for each algo-
rithm’s estimated neuronal fraction compared to the DNAm-based neuronal frac-
tions (Figure 2.1). RMSE quantifies the degree of bias, i.e., how much our cell type
estimates (RNA composition estimates) deviate from the absolute cell type fractions,
with smaller values corresponding to the cellular composition and RNA composition
being more similar. R2 quantifies the amount of information our estimates contain
about how the absolute cell type fractions vary in the population being studied, i.e.,
how much variability of the cell type fractions, across individuals, is captured by our
composition estimates. Houseman (Figure 2.1a), MuSiC (Figure 2.1b), and NNLS
produced concordant (high correlation; Houseman R2 = 0.51, p < 2.20× 10−16; Mu-
SiC R2 = 0.56, p < 2.20×10−16; NNLS R2 = 0.54, p < 2.20×10−16 ) but biased (high
RMSE, > 0.35) neuronal fraction estimates. CIBERSORT produced more discor-
dant (moderate correlation; R2 = 0.25, p = 5.13×10−03) neuronal fraction estimates
(Figure 2.1c), but with less bias (low RSME, 0.09). We found that CIBERSORT,
compared to either MuSiC or the Houseman RNA approach, was the most accurate.
However, its estimates provided the least information (R2 value) about the variability
of the estimates based on DNAm data. In comparing the R2 metric across the three
approaches, we found that MuSiC provided the most information about the observed
variability of the observed cell type proportions among the 223 individuals but was
the most biased. These results suggest that all four of these approaches overestimated
the proportion of neurons in bulk brain tissue, even under the simplest application
to deconvoluting two distinct cell populations. However, it was unclear how much
algorithm parameters and reference dataset differences (in regards to technology and
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brain region) contributed to the performance of these methods.
2.3.2 Methods for reducing bias in cellular deconvolution
Table 2.1. Cell sizes used for deconvolution.
 
Cell type NAc 50 
genes (UMIs) 
NAc 25 
genes (UMIs) 
NAc all 
genes (UMIs) 
Temporal 
cortex, 
Darmanis 
et al. 
(Counts) 
osmFISH cell 
Area (μm2) 
osmFISH 
nRNA 
(intensity) 
Glial  710.63 453.24 5763.55 12879.73 90.87 180.46 
Neuronal  4513.58 2793.54 29884.65 18924.66 122.96 198.86 
Neuronal
/glial 
ratio  
6.35 6.16 5.19 1.47 1.35 1.1 
UMI, unique molecular identifier, counts=  log2(cpm+0.5), intensity = sum of probe intensities across 24,048 
genes.  
 
Many of the above deconvolution strategies have several parameters whose ad-
justment could reduce the observed bias (i.e., maximize accuracy) and increase the
concordance between these neuronal fractions. The MuSiC algorithm particularly
has an interpretable ”cell size” (see Methods) parameter used in the deconvolution
process. Different cell types could have more or less absolute RNA abundance, for
example if they were larger or smaller, or if they were more or less transcriptionally
active. We hypothesized that the overestimation of neuronal fractions resulted from
neurons being larger and more transcriptionally active. However, this ”cell size”
parameter, regularly defined by the algorithm as the average expression level for a
given cell type summed across genes, is estimated directly from the reference cell
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type-specific RNA-seq profiles by default (see Methods). However, some scRNA-seq
(or snRNA-seq) library preparation and sequencing strategies, like the Fluidigm C1
system, may normalize cDNA libraries to the same concentration prior to sequenc-
ing, which will remove potential variability in RNA abundances across cell types. We
therefore sought to use external data to better estimate these cell size parameters
(Table 2.1) and assessed the resulting effects on cellular deconvolution accuracy.
Fig. 2.2. Deconvolution in bulk NAc data based on a single nucleus RNAseq (snRNA-
seq) reference dataset from the same brain region; Scatter plots comparing the estimated
neuronal proportion obtained for each individual using the Houseman approach with DNAm refer-
ence dataset vs neuronal proportions obtained using (a) MuSiC with default settings and a snRNA-
seq NAc reference dataset, (b) MuSiC based on a snRNA-seq NAc reference dataset with cell sizes
for each cell type estimated using osmFISH cell area (mouse), and (c) MuSiC based on a snRNA-
seq NAc reference dataset with cell sizes for each cell type estimated using osmFISH total RNA
abundance (mouse) per cell type.
First, we used external ouroboros single-molecule fluorescence in situ hybridiza-
tion (osmFISH) data from mouse somatosensory cortex[43] to construct two different
types of cell size parameters for the MuSiC algorithm (as data from NAc did not ex-
ist). We extracted the estimates of both cell size (via their provided segmentations)
and total RNA abundance (via the sum of all gene fluorescence signal) aggregated
across neuronal and non-neuronal cell types. We subsequently utilized these esti-
mates as proxies for cell size in human RNA-seq data when deconvoluting neuronal
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fractions. In these data, comparing neurons to non-neurons, neurons were both
larger (123 vs 91 µm2, p < 2.20 × 10−16) and had more total RNA (199 vs 180
intensity, p = 1.73 × 10−05) as we observed in the estimated cell size in the MuSiC
algorithm using the Darmanis dataset (18,925 vs 12,880 normalized counts). We
did not observe any improvement in the concordance (osmFISH cell area R2 = 0.55,
p < 2.2× 10−16; osmFISH totalRNA R2 = 0.54, p < 2.2× 10−16 ) or accuracy (osm-
FISH cell area RMSE = 0.39; osmFISH totalRNA RMSE = 0.43) of the estimated
cell type fractions when we compared our results from default settings to those based
on applying cell size proxies using mouse data (Figure A.2 a-b). These results may
not be particularly surprising, given the numerous differences between mouse and
human morphology, and the different brain regions profiled.
We then generated snRNA-seq dataset from 2 postmortem NAc donors and 4,169
total nuclei to produce more comparable cell type specific cell size (see Methods) pa-
rameters and reference expression profiles (see Methods). First, we used the NAc
reference dataset at the single nucleus level and ran the MuSiC algorithm with default
settings, which used both NAc-based cell sizes and expression profiles, to deconvo-
lute neuronal fractions (Figure 2.2a). We confirmed that, on average, neurons had
more total RNA than non-neurons using this NAc snRNA-seq dataset (103 vs. 72
unique molecular identifiers [UMIs] per gene, p < 2.2 × 10−16). Furthermore, while
there was a high correlation among neuron-specific gene expression effects across
the NAc and temporal cortex (Darmanis et al.) reference profile datasets, we ob-
served genes with different magnitudes of effects based on differential expression
results between neuronal and non-neuronal cell types (Figure A.33). When using
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Table 2.2. Bias and concordance results for deconvolution of bulk NAc data using
each cell size and gene expression reference dataset.
Method Cell size Reference dataset 
scRNA-seq in temporal 
cortex (Darmanis et al.) 
snRNA-seq in NAc 
Concordance 
(R2) 
Accuracy 
(RMSE) 
Concordance 
(R2) 
Accuracy 
(RMSE) 
MuSiC 
None 0.54 0.45 0.54 0.08 
scRNAseq in 
temporal cortex 
(Darmanis et al.) 
0.56 0.37 0.58 0.05 
snRNAseq in NAc 0.59 0.08 0.71 0.17 
snRNAseq in NAc 
(Top 25 genes) 
0.59 0.06 0.71 0.18 
snRNAseq in NAc 
(Top 50 genes) 
0.59 0.05 0.72 0.18 
osmFISh-Cell area 0.55 0.38 0.57 0.05 
osmFISh-Total RNA 0.54 0.43 0.54 0.06 
CIBERSORT N/A 0.25 0.09 N/A N/A 
NNLS N/A 0.54 0.40 0.72 0.22 
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both the NAc-based cell size and gene expression reference profiles, we observed a
substantial improvement in both the concordance and the RMSE for the estimated
neuronal fractions compared to using the temporal cortex dataset only. However, the
estimates were still biased, and this bias increased as the neuronal fraction across
individuals increased, suggesting that the NAc-based cell sizes together with the es-
timated abundance may be incorrectly characterizing the true underlying neuronal
expression level for these individuals. Eliminating the cell size parameter resulted in
similarly reduced concordancies in both the temporal cortex and the NAc reference
datasets, but increased accuracy only using the NAc reference dataset (Table 2.2).
This implies that the underlying broad cellular composition was well captured by
the gene abundance information for a matched brain region.
Fig. 2.3. Deconvolution in bulk NAc data using gene expression profiles from the
temporal cortex (Darmanis et al) and different estimates of cell size; Scatter plots com-
paring the neuronal fraction estimated for each individual using DNAm data and the Houseman
method vs neuronal fractions based on scRNA-seq data and estimated using MuSiC with (a) cell-size
estimated using all genes expressed in the NAc snRNAseq reference dataset, (b) cell-size estimated
using the top 50 cell type discriminating genes in the NAc snRNAseq reference dataset, and (c)
cell-size estimated using the top 25 cell type discriminating genes in the NAc snRNAseq reference
dataset.
We then combined different estimates of cell size parameters (NAc snRNA-seq
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versus osmFISH) and gene expression reference profiles (NAc snRNA-seq versus tem-
poral cortex scRNA-seq ) and assessed the effects on deconvolution accuracy in bulk
NAc RNA-seq data. When running MuSiC using the estimates of cell size based
on osmFISH data with the NAc expression reference profiles, we observed further
improvements in the bias of the estimated cell type fractions but saw a minimal dif-
ference in the concordance (Figure 2.2b and c). Surprisingly, when we used only the
Darmanis cell type-specific expression levels, the best (least biased and most con-
cordant) deconvolution results were produced using cell sizes estimated from NAc
snRNA-seq data, with improvements in both the concordance and the RMSE (Fig-
ure 2.3a). Specifically, when we compared the R2 and the RMSE estimates to those
observed under the default setting for the Darmanis reference with the mismatched
brain region, we see a small (6% relative change, p = 3.3 × 10−02) increase for the
concordance and a substantial (78% relative change, p < 1 × 10−04 ) decrease for
the RMSE. We further refined the NAc cell size estimates using sets of the top 25
and 50 cell type discriminating genes (see Methods), which slightly improved our
estimates of the absolute cell type fractions (Figure 2.3b and 2.3c). Both the con-
cordance (7% relative change, p = 3.5 × 10−02) and RMSE (86% relative change,
p < 1 × 10−04) improved even more when compared to the default approach using
a mismatched reference dataset. Across all approaches, the most accurate (least bi-
ased) result occurred when we used cell sizes estimated from Darmanis scRNAseq
data and gene expression from NAc snRNA-seq data, while the most concordant
results were observed when we used NAc snRNAseq data exclusively.
In summary, when we used a region-matched appropriate dataset - NAc snRNA
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data - as the reference, or to derive estimates of the cell size, we observed that
estimates of the cell type proportions generally improved (Table 2.2, Figure 2.2 a
and Figure 2.3a-c). In settings where we had a mismatched reference dataset (e.g.,
mismatched on brain region or species), incorporating estimated cell sizes obtained
from the matched brain region (NAc) provided the best result in metrics for both
concordance and accuracy, and we slightly improved these metrics when we refined
the gene sets used to estimate the cell sizes.
2.4 Discussion
Statistical deconvolution strategies have emerged over the past decade to estimate
the proportion of various cell populations in homogenate tissue sources like blood
and brain from both gene expression and DNAm data. Our results together suggest
that many existing RNA deconvolution algorithms estimate the RNA composition
of homogenate tissue, e.g. the amount of RNA attributable to each cell type, and
not the cellular composition, which relates to the underlying fraction of cells. This
was evident by the consistent overestimation of larger and more transcriptionally
active neuronal cells. We have identified that incorporating cell size parameters
into RNA-based deconvolution algorithms can successfully recover cellular fractions
in homogenate brain RNA-seq data. We have lastly shown that using both cell
sizes and cell type-specific gene expression profiles from brain regions other than the
target/user-provided bulk tissue RNA-seq dataset consistently resulted in overesti-
mating neuronal fractions. We have developed an extension of the MuSiC framework
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[26] that allows for the incorporation of independent cell size estimates, and have fur-
ther provided cell size estimates for human brain (shown in Table 2.1) as a part of
the package: https://github.com/xuranw/MuSiC.
Characterizing cellular heterogeneity is especially important in human brain,
where the underlying cell types can have diverse functions and disease associations
that could be missed in studies of bulk tissue [17]. Here we show that RNA-based
deconvolution for just two cell populations - neurons and non-neurons - largely fails
to estimate the underlying cellular composition of bulk human brain tissue across
a variety of algorithms and strategies. We quantified the diverse range of neuronal
fractions estimated by several popular algorithms to better understand the effects
of reference cell type-specific expression profiles and differences in cell size and/or
activity profiles on deconvolution. We specifically examined the common scenario of
performing RNA deconvolution using cell type-specific reference datasets that can
be fundamentally different from user-provided homogenate tissue target datasets,
for example differing in profiled brain region, sequencing technology and/or cellular
compartment. These problems are likely magnified in human brain tissue compared
to suspended cells like blood, where deconvolution strategies are more easily vali-
dated against true cell fractions obtained by routine complete cell counts [11]. We
lastly emphasize caution when performing RNA-based deconvolution using many cell
types ( i.e., more finely-partitioned cell classes) without having the ability to validate
cell counts on at least a subset of samples.
We therefore offer several recommendations for performing RNA-based deconvo-
lution in bulk human brain gene expression data, particularly when aiming to identify
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cellular, and not RNA, composition.
1. Providing estimates of cell size for each reference cell type improves the con-
cordance and reduces bias when performing RNA deconvolution to estimate
cellular fractions. Biologically-motivated and valid external estimates of cell-
size improve the accuracy of the estimated cell type fractions, even when gene
expression profiles for reference cell populations are obtained from other brain
regions (Figure 2.3). The exact biological interpretation of these estimated
cell sizes, particularly when estimated across species, is arguably unclear, but
likely relates to correcting for absolute RNA abundance and differences in tran-
scriptional activity between cell populations. Regardless of the method used
for deriving cell sizes, neurons consistently had more RNA than glia. We note
that our recommended strategies for estimating cell size have only been as-
sessed for broad classes of cell types, and further work is needed to validate
extensions to more stratified subclasses of cells.
2. The concordance and bias improvements using full-length single cell sequenc-
ing from a different brain region (temporal cortex), rather than single nuclei
RNA-seq from the target brain region (NAc) highlighted the importance of
comparability between reference gene expression profiles and the homogenate
tissue expression levels. While previous reports have identified high correlation
between nuclear and cytosolic gene expression levels in both bulk[50] and single
cell[39, 51] resolution, comparable absolute (and not relative) expression levels
are seemingly important for the accuracy of these RNA-based cellular decon-
volution algorithms. There further is an experimental design tradeoff between
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profiling more nuclei (1000s) using 3′ technologies like 10x Genomics Chromium
Single Cell Gene Expression compared to profiling fewer nuclei (or cells, 100s)
using full-length sequencing technologies like SMART-seq if researchers wish
to generate their own reference profiles.
3. Using reference cell type-specific expression profiles from comparable brain re-
gions as the bulk RNA-seq target dataset is important, and can especially
greatly increase the concordance of these RNA deconvolution strategies with
neuronal fractions.
The choice of maximizing accuracy (by minimizing bias) versus increasing concor-
dance in assessing these algorithms is an important consideration, particularly when
generating custom expression reference profiles is prohibitive (Table 2.2). These two
objectives largely relate to whether the goal of RNA deconvolution is to estimate
cell fractions (and maximize accuracy) or RNA fractions (and maximize concor-
dance). Estimation of RNA fractions (by maximizing concordance) may be sufficient
to control for potential confounding due to composition differences between outcome
groups [17]. We note this can also be accomplished using ”reference-free” deconvolu-
tion [19] or through the estimation of potentially sparse principal components[14, 21]
that control for relative differences in cellular composition. However, estimation of
cellular fractions (and maximizing accuracy) is arguably more useful, both for as-
sessing human brain tissue dissection during data generation and to identify cell
type-specific effects when using these cellular fractions in downstream differential
expression analyses[52].
Together, our results demonstrate that many RNA deconvolution algorithms do
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not produce accurate cellular fractions when estimating only two cell classes (neurons
and non-neurons). We offer several strategies and corresponding software to assess
and improve accuracy that can be applied across multiple datasets and cell types.
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Chapter 3
Retinal transcriptome and eQTL
analyses identify genes associated
with age-related macular
degeneration
3.1 Introduction
AMD, a leading cause of incurable vision impairment, results in progressive loss of
photoreceptors, particularly in the macular region of the retina[53]. AMD-GWAS
have identified strong and highly replicated association of 52 independent SNPs at 34
genetic loci accounting for more than 50% of the heritability[54]. To derive mechanis-
tic insights and further advance AMD genetics, we initiated the EyeGEx project to
elucidate genetic regulation of gene expression in the human retina. We characterized
523 postmortem retinas from 517 donors by using the Minnesota Grading System
(MGS)[55], with criteria similar to the Age-related Eye Disease Study (AREDS)[56]
(Fig. B.1 and Supplementary Data 1). MGS1 donor retinas demonstrated no AMD
features and served as controls, whereas MGS2 to MGS4 samples represented pro-
gressively more severe disease stages.
3.2 Methods
3.2.1 Study subjects
Postmortem human donor eyes were procured by the Minnesota Lions Eye Bank
after informed consent from the donor or next of kin was obtained, in accordance
with the tenets of the Declaration of Helsinki. These studies were approved by the
institutional review boards of the University of Minnesota and National Eye Insti-
tute, National Institutes of Health. Exclusion criteria for donors included a history of
diabetes or glaucoma. Donors were also excluded from this study if, upon examina-
tion of donor macular images, there were clinical symptoms of diabetic retinopathy,
advanced glaucoma, myopic degeneration, or the presence of atypical debris in the
eyes. Donor eyes were enucleated within 4h of death and stored in a moist chamber
at 4°C until retinal dissection was performed. Dissection and classification of donor
retinas for AMD were carried out according to the four-step MGS as previously
described[55, 57]. Tissue sections were flash frozen in liquid nitrogen and stored at
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-80 C until further processing. Samples with ambiguous or no MGS levels were ex-
cluded from downstream analysis. Details of donor characteristics are described in
Appendix B.
3.2.2 RNA-seq, genotyping, and quality control
Details of RNA-seq, genotyping, and quality control are provided in Appendix B.
Batch correction
Surrogate variables were identified and estimated for known batch effects as well as
latent factors by using the supervised SVA (SSVA version 3.28.0/3.24.4) method[58,
59, 60] based on the following model:
gene expression ∼ MGS + Sex + Age
Negative-control genes for SSVA were selected from a reported list of 3,804 house-
keeping genes that are uniformly expressed across 16 human tissues[61]. The Pearson
method was used to determine correlations between all significant surrogate variables
identified by SSVA and possible sources of variation, including biological and techni-
cal factors. Known batch effects were assessed with Principal Variance Component
Analysis (PVCA) (version 1.23.0) before and after batch correction[62]. All surro-
gate variables identified by SSVA were used for batch correction. Additional details
are described in Appendix B.
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3.2.3 Reference transcriptome
We generated the control human retina transcriptome profile from 105 MGS1 retinas
by applying two criteria for gene expression: the first was to remove weakly expressed
genes across all MGS stages (i.e., ≥1 CPM in ≥10% of all 453 samples), and the
second was to describe the transcriptomic landscape in the retina with greater confi-
dence (i.e., ≥2 CPM in ≥50% of all 105 MGS1 samples). We calculated the cumula-
tive transcriptional output as previously defined[63] by converting CPM into FPKM
values to take gene length into account. Similarities in transcriptomes between the
retina and 53 GTEx tissues were observed with a gene filter of ≥1 CPM in ≥10%
of all samples across all tissues, whereas a different gene filter, namely ≥1 CPM in
≥10% of samples within each tissue, was applied to identify genes whose expression
was at least tenfold higher in the retina than in other tissues. Pathway enrichment
analysis was performed with GO biological-process terms[64, 65] within clusterPro-
filer version 3.4.4 (ref. [66]) by using a Benjamini-Hochberg-adjusted P value ≤ 0.05
as the significance threshold. The analysis and classification of potentially novel iso-
forms of known genes and unknown intergenic transcripts were performed with the
Cufflinks suite, version 2.21[67, 68]. Further details are provided in Appendix B.
3.2.4 cis-eQTL mapping
The analysis included 406 individuals for whom genotype and retina gene expression
data were available, 17,389 genes expressed at ≥1 CPM in at least 10% of the retina
samples, and 8,924,684 genotyped and imputed common variants. Cis-eQTL analy-
sis was conducted with QTLtools version 1.0[69], with a linear model to adjust for
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disease status (MGS level), age, sex, population stratification (ten principal compo-
nents), and batch effects (21 surrogate variables). In the first step of the analysis,
the variant most associated with each gene was selected, and then permutation was
used to determine the distribution of its test statistic under the null. This procedure
was subsequently used to obtain the P value for each gene. These P values were ad-
justed for multiple testing with the q-value approach[70] at the desired type I-error
level. The second step of the analysis involved the identification of all eVariants with
independent effects on a given eGene (significant gene from the first stage). This
step was done by using the gene-level thresholds derived from the first stage and
then identifying which variants exhibited nominal P values below these thresholds,
on the basis of the forward-backward stepwise regression algorithm.
3.2.5 GTEx comparison
To calculate π1, we compared our cis-eQTL discoveries by using the following defi-
nition:
π1 = P (cis-eQTL in discovery tissue is significant in replication tissue|cis-eQTL in discovery
tissue was also analyzed in the replication tissue)
Thus, for each cis-eQTL (gene-variant combination) we required that the combina-
tion be analyzed in both tissues being compared.
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3.2.6 GWAS lead-variant analysis
Forty-one lead variants from AMD-GWAS3 were analyzed. Those not found either
were not in the reference dataset used for imputation (six variants) or did not pass
our MAF threshold of < 1% (five variants). Matrix eQTL version 2.1.1[71] was then
used to obtain the marginal associations by using the same cis criteria, which were
then corrected for multiple testing only for the number of variants tested, by using
the Bonferroni method with a type I error rate of 5%.
3.2.7 Enrichment
In general, we processed quantile-quantile plots for each GWAS dataset by removing
all SNPs within ±1 Mb of the known GWAS signals and subsetting to variants with a
MAF of at least 5%, after removing variants in the major histocompatibility region.
The remaining variants were then grouped according to eQTL characteristics. Details
can be found in Appendix B.
3.2.8 Colocalization
Likely colocalizing variants between the eQTL and the GWAS data were identified
with eCAVIAR version 2.0 (ref. [8]) (Appendix B) on the basis of marginal statistics
from the cis-eQTL analysis and from AMD GWAS[54].
31
3.2.9 TWAS
To perform the TWAS, the log-transformed, SSVA-corrected expression data from
the 406 samples in our dataset that both passed RNA-seq and genotyping quality
control were inverse-normal transformed (rank offset=3/8)[72] to moderate the in-
fluence of potential outliers. Expression was then controlled for sex, age, and the ten
population-structure variables determined by Eigenstrat version 7.2.1[70, 73]. For
each gene, we took the subset of SNPs within 1 Mb of its start or end site that had
GWAS statistics[54] by using VCFtools version 0.1.15[74]. TWAS implementation
was performed according to Gusev et al.[75], heritability was calculated with GCTA
version 1.21[76], and genetic control of expression was modeled with mixed models,
LASSO, or elastic net (α=0.5), depending on which of the three methods produced
the highest fivefold cross-validation R2.
The effect sizes from these models acted as weights. Weighted z scores were
summed for each gene, and this gene-trait association statistic was divided by its
standard deviation while LD was accounted for between GWAS statistics. Stan-
dardized gene-level scores were tested against the standard normal distribution on
both sides. The FDR was calculated to account for multiple testing across genes with
calculated P values; genes that had an FDR<0.05 were considered significant. We
also determined whether genes passed a 0.05 significance threshold after Bonferroni
correction. Genes were then filtered according to their model expression fit; genes
with a genetic model R2 < 0.01 were discarded.
We also performed a permutation test to determine the role that the eQTL data
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played in the associations: for genes with a TWAS P value< 0.001, weights were ran-
domly assigned to SNPs, and the gene-level z scores were recomputed for an adaptive
number of iterations to generate a null distribution against which the original TWAS
statistic was tested[75]. Details on the methods used for the conditional TWAS test
can be found in Appendix B.
3.2.10 Differential expression
Differential expression was assessed with the limma package in R version 3.34.2[77]
with a significance threshold of FDR≤ 0.20. MGS was treated as an ordinal vari-
able in pairwise comparisons between controls and each AMD stage. Differential
expression was performed with adjustments for sex and batch effects (22 surrogate
variables), with or without age as a covariate. Age was the most significant non-
genetic risk factor for AMD, and age-related gene expression changes would proba-
bly be relevant to AMD. We therefore also performed differential expression analysis
without correcting for age to generate a comprehensive list of candidate genes that
require further investigation to ascertain their contribution to AMD pathogenesis.
Additional differential expression analyses, performed after the removal of samples
with conditions such as hypertension, high cholesterol, and cardiovascular disease,
were consistent across all comparisons made (data not shown).
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3.2.11 Gene set enrichment analysis and leading-edge anal-
ysis.
GSEA was performed by preranking genes by significance and the direction of fold
change from differential expression analysis, and then testing for association with
the GO biological-process gene set deposited in the GSEA MSigDB resource ver-
sion 2.2.4[78]. Leading-edge analysis was performed on gene sets reaching a signifi-
cance threshold of FDR≤ 0.25 and absolute normalized enrichment score of ≥ 2.0.
Significant gene sets were further classified into common functional categories by
visualization of the GO structure as described in Appendix B (see URLs).
3.2.12 Weighted gene-correlation network analysis
Weighted gene-correlation network analysis[79] was performed on all 453 samples that
passed RNA-seq quality control, to group genes by expression profile, with the asso-
ciated software WGCNA version 1.51. The log-transformed expression values were
corrected for age, sex, and batch effects (determined by SSVA[59, 60]). Adjacency
was calculated with Spearman correlation, and the power by which we raised the
absolute values of the correlation to obtain the adjacency matrix was k=3. Through
hypergeometric testing, at a significance threshold of 0.05 after Bonferroni correction
for multiple testing, modules were assessed for the enrichment of the following types
of genes: (i) genes deemed relevant to macular-degeneration pathogenesis in the lit-
erature, (i) genes within 500 kb of the 34 AMD loci identified through GWAS[54],
and (iii) genes identified as leading edge by GSEA[78]. A list of genes relevant to
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AMD was obtained from a previous published study[80] and was updated through
extensive PubMed searching (through December 2017) with one of several search
terms (Appendix B). Pathway analysis was performed on each module with GO
biological-process terms[64, 65] through clusterProfiler version 3.4.4[66]. The con-
nections between genes in modules were visualized with Cytoscape version 3.5.1[81]
3.3 Results
3.3.1 Samples and sequencing
RNA-seq of the donor retinas provided 32.5 million (median) uniquely mapped
paired-end reads per sample, with a 94% mapping rate to Ensembl release GRCh38.p7
(Fig. B.2). After RNA-seq quality control (Appendix B), 105 MGS1, 175 MGS2,
112 MGS3, and 61 MGS4 samples were selected for further analyses. The reference-
transcriptome profile was generated from MGS1 control retinas (Fig. 3.1a and Sup-
plementary Data 2[7]) and included 67% of the protein-coding genes (13,662) and
6.7% of the noncoding genes (1,462) in Ensembl, in agreement with findings from
a previous study[82]. High-abundance genes (186 genes showing≥100 fragments per
kilobase of transcript per million mapped reads (FPKM)) accounted for half of the
Ensembl-annotated transcripts in our RNA-seq data and were enriched in visual
perception, metabolic processes, and energy homeostasis (Fig. B.3a and Supplemen-
tary Data 2[7]). Overall, 34% of the retinal transcripts were of mitochondrial origin
(Fig. 3.1a and Fig. B.3b), thus reflecting the high concentration of mitochondria in
photoreceptors[83], the predominant cell type in the human retina[84].
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Genome-guided transcript assembly supplemented 410 putative novel long in-
tergenic noncoding RNAs (lincRNAs) and 2,861 proteincoding isoforms of genes
expressed in the retina (Fig. B.3c and Supplementary Data 2[7]). The putative lin-
cRNA isoforms were not enriched in any biological pathway. In contrast, predicted
gene function and classification of novel protein-coding isoforms showed enrichment
in Gene Ontology (GO) biological processes involving synapse structure or activity
(adjusted P value=1.37× 10−2), sensory perception (adjusted P value=1.64× 10−2),
regulation of membrane potential (adjusted P value=3.45 × 10−2), and photore-
ceptor maintenance (adjusted P value=3.45 × 10−2). The multidimensional scaling
plot of the retina reference transcriptome against the GTEx v7 data distinguished
tissue-specific clusters consistent with the defined biological replicates, whereas tis-
sue hierarchical clustering on the mean gene expression levels revealed a high degree
of similarity between the brain and retina (Fig. 3.1b, Fig. B.3d and Fig. B.4). We
identified 247 genes with tenfold or higher expression in the retina than in at least
42 of the 53 GTEx (v7) tissues (Supplementary Data 2[7]).
3.3.2 A comprehensive resource of Retina eQTL
Mapping of cis-eQTLs (as defined by SNP-gene combination within ±1 Mb of the
transcriptional start site of each gene; Methods) identified 14,565 genetic variants
(eVariants) controlling expression of 10,474 genes (eGenes) at a false-discovery rate
(FDR) ≤ 0.05; these included 8,529 known protein-coding and 1,358 noncoding genes
(Fig. 3.1c and Supplementary Data 3[7]). The strength of association was contingent
on the eVariants distance from the transcriptional start site of its corresponding
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Fig. 3.1. EyeGEx: Retinal transcriptome and eQTL analyses. a, Reference transcrip-
tome output. Top: Fraction of expressed genes in Ensembl gene biotypes. Below: Percentage of
gene expression in distinct gene subtypes. b, Within-tissue sample similarity and transcriptome
comparison across the retina and the GTEx tissues (v7) based on normalized gene expression levels.
Each color represents a distinct tissue. Left: multidimensional scaling. Right: tissue hierarchical
clustering. c, A summary of retinal cis-eQTLs, eGenes and eVariants. 1.8% of the top eVariants
(14,565) regulate more than one eGene. Variants in LD with the most significant eVariant are
indicated as LD proxies. LD, linkage disequilibrium. d, The proportion of cis-eQTLs in the retina
(y-axis) that are detected in GTEx (x-axis), ordered by the sample size of each tissue. Color and
shape of each point represent the tissue and sample size, respectively.
eGene (Fig. B.5). Most of the retinal cis-eQTLs were present in at least one GTEx
tissue, and more retinal eQTLs replicated with an increase in GTEx tissue sample
size (Fig. 3.1d). The proportion of GTEx cis-eQTLs replicated in the retina was
larger for GTEx tissues with smaller sample sizes[1](Fig. B.5f). Almost one-third
of the retina-only eQTLs observed in our study, compared with those reported by
GTEx for other tissues, were attributable to the relatively larger sample size (Fig.
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B.6a,b).
3.3.3 Integrative analysis of Retina cis-regulatory effects with
AMD risk
We examined the global role of eQTLs in the genetics of AMD. Q-Q plots iden-
tified cis-eQTL SNPs to be enriched for AMD associations with more pronounced
enrichment for eVariants shared across several tissues[85, 86], and this relationship
remained relatively consistent across all other complex disease phenotypes examined
(see Fig. B.5g). We then integrated retina eQTL results with associations reported
across loci identified by AMD-GWAS (Table B.1). Nine lead SNPs at the GWAS loci
were significant eQTLs in the retina for 19 SNP-gene associations. Similar analysis
showed a comparable number of lead SNPs as eQTLs in several GTEx tissues (for
details see Supplementary Data 3[7]). To ascertain the most likely causal variants, we
applied eCAVIAR which calculates the colocalization posterior probability (CLPP)
to identify the variant responsible for both AMD-GWAS and retina-eQTL signals,
after accounting for local linkage disequilibrium (LD) patterns. At the recommended
threshold of 1% CLPP[8], we discovered likely causal SNPs and underlying target
genes at six AMD loci (Table B.1, Fig. 3.2a). At two of these loci (B3GALTL and
RDH5/CD63), the lead GWAS signal was identified as the most likely causal SNP,
whereas the likely causal variant was distinct from the lead SNP at four other loci;
SLC16A8 (rs5756908), ACAD10 (rs7398705), TMEM/VTN (rs241777), and APOE
(rs157580) (Table B.1).
We then leveraged retinal eQTLs and the most recent GWAS data 3 to detect
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novel AMD risk genes in a transcriptome-wide association study (TWAS) 14 using
our retina transcriptome data. Gene expression was modeled using SNPs within a 1
Mb window using mixed models, Least Absolute Shrinkage and Selection Operator
(LASSO), and elastic net. The TWAS identified 61 transcriptome-wide significant
gene-AMD associations (FDR≤0.05), which passed a gene expression model fit filter
(R2>0.01) (Supplementary Data 4[7]). We detected 38 genes within 1 Mb of 13
AMD-GWAS loci, and of these, 28 passed genome-wide Bonferroni correction (Fig.
3.2b). TWAS analysis also revealed 23 genes outside the GWAS loci (Fig. 3.2c);
these genes fell within 16 separate regions (+/− 1 Mb). Three of these - RLBP1,
PARP12 and HIC1 - were the only significant genes in the region and remained
so even after Bonferroni correction, thus representing the strongest new candidate
AMD-associated genes (Fig. 3.2d). Conditional testing of the full 61 significant
(FDR≤0.05) candidates revealed 47 independent signals (α=0.05). A permutation
test (see Methods) demonstrated that two of the genes (MTMR10 and SH3BGR),
which were at least 1 Mb outside of any GWAS region, had TWAS associations
significantly informed by eQTL data after Bonferroni correction for the number of
genes permuted (α=0.05; Supplementary Data 4[7]). However, we note that the test
is overly conservative in the presence of LD.
We compared the data from eQTL, eCAVIAR, and TWAS to highlight the most
plausible target genes; B3GLCT and BLOC1S1 were each identified as the only target
gene at two AMD loci by all three methods, whereas SH2B3, PLA2G12A, PILRB,
and POLDIP2/TMEM199 were likely targets at four additional loci identified by two
methods (Table 3.1 and Fig. B.7). A comparison of these findings with those reported
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Fig. 3.2. Genes and variants associated with AMD. a, Violin plots of the relationship
between the variant at a GWAS locus and the target gene identified by eCAVIAR. For three
GWAS loci, the target gene (shown here) was the only one significantly associated (FDR ≤ 0.05)
by TWAS. b, TWAS results for genes that pass Bonferroni-corrected significance identified within
1 Mb on either side of the lead SNP at previously-reported GWAS loci. PLEKHA1 (TWAS p-value
=7.91× 10−119) was omitted for appropriate scaling. c, Manhattan plot of TWAS-identified genes
outside the reported lead SNP (> 1 Mb on either side) at the GWAS loci. Of the genes with
expression model R2> 0.01, 23 genes met the FDR threshold of 0.05 (red line), and three of these
passed Bonferroni-corrected significance (cutoff shown as blue line). d, LocusZoom plots showing
empirical GWAS association for top three TWAS signals outside GWAS loci. The diamonds indicate
top eVariants for independent eQTL signals. The coloration of the points is determined by their
LD with respect to the eQTL in purple. The top GWAS variant in the region is also labeled. The
recombination rate is shown as a blue line.
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in GTEx[1, 87] showed that the contribution of these SNPs to gene regulation varied
across different tissues (Supplementary Data 3[7] and Appendix B.3.4). Specifically,
no single nonretina tissue showed replication of the retinal findings for all SNP-target
gene combinations (Supplementary Data 3[7]).
Table 3.1. Significant target genes and variants for AMD susceptibility at GWAS
loci after eQTL, eCAVIAR and TWAS analyses.
Differential expression analysis of retinal transcriptomes identified 14 genes with
and 161 genes without age correction in advanced AMD (FDR≤ 0.20) (Supple-
mentary Data 5[7] and Fig. B.8a). Thus, similarly to results for other complex
diseases[88, 89], our differential expression analysis did not detect many gene expres-
sion changes, probably because of heterogeneity caused by aging, polygenic inheri-
tance, and environmental factors. We then examined biological pathways by gene set
enrichment analysis (GSEA). Immune-regulation and cholesterol-metabolism path-
ways, previously implicated in GWAS[54], were upregulated in early and advanced
AMD, whereas pathways associated with synapse development and function were
largely and exclusively downregulated in intermediate AMD (Supplementary Data
5[7]). We note that most of the genes within susceptibility loci for advanced AMD
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did not appear to be associated with intermediate AMD despite sufficient power[54].
Thus, intermediate AMD may not be a transitional stage between early and advanced
AMD but a separate entity with unique and distinct genetic underpinnings that re-
quire further exploration. Furthermore, weighted genecoexpression network analysis
of all samples suggested that several of the pathways implicated in AMD operate
through closely connected networks in the retina (Fig. B.8b,c and Supplementary
Data 6[7]).
3.4 Discussion
GWAS have successfully identified variants at hundreds of loci that contribute to
health- and disease-associated traits, thereby defining their broad genetic architecture[90,
91]. Interpretation of GWAS findings, however, remains a major challenge, because
a large proportion of associated variants are not in protein-coding genomic regions,
and their effects on specific phenotypes often individually appear to be small[92, 93].
eQTL analysis in disease-relevant tissues appears to be a prominent tool for biologi-
cal interpretation of GWAS loci[85, 94]. Owing to the large sample size, we were able
to identify 14,856 eQTLs that modulate retinal gene expression, a substantial pro-
portion of which are not reported in GTEx v7 data. Moreover, we connected the lead
GWAS signal to specific target genes at six known AMD-associated loci by at least
two lines of evidence. Two of the target genes were validated by three independent
methods: B3GLCT encodes a glucosyltransferase[95], and its loss of function leads
to Peters plus syndrome[96]; BLOC1S1 encodes a subunit of a multiprotein complex
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associated with the biogenesis of an organelle of the endosome-lysosome system[97],
and its altered function can affect synaptic function[98]. Thus, altered expression of
B3GLCT and BLOC1S1 might affect extracellular-matrix stability or signaling and
the degradation of unwanted/recycled proteins, respectively, thereby contributing to
AMD pathogenesis. We attribute the lack of obvious target genes at the remain-
ing AMD-GWAS loci to multiple factors, including LD structure, variants affecting
expression in trans or in other AMD-relevant tissues (such as retinal pigment ep-
ithelium and choroid), and the power of this study. Interpretation of eVariants that
regulate multiple genes at a particular locus requires further biological validation.
AMD is notable among complex traits because of its high heritability and large
effect sizes for individual GWAS SNPs[54]. We show that variants associated with
gene expression across many tissues as eQTLs, as opposed to those with only tissue-
specific associations, are enriched in AMD associations despite high tissue specificity
of the disease itself (Supplementary Data 3[7] and Fig. B.5g). We hypothesize that,
at least in part, such associations reflect larger, more robust effects among the shared
eQTLs. Not surprisingly, the retina is the only tissue for which we detected regulation
consistently across all six identified SNPs (Supplementary Data 3[7]). In addition, 36
of the 61 retina-identified TWAS candidates were significant (FDR≤0.05) in at least
one GTEx tissue. The remaining candidates could not be analyzed because they had
no expression or heritability in the GTEx tissues, or they were not replicated in any
other tissue. Our results corroborate findings from recent studies[86, 99] and suggest
that the best way to increase power for gene discovery through TWAS and similar
approaches is to increase the diversity of tissues for greater resolution of the effects
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of regulatory variants. We emphasize, however, that eQTL effects detected only in
a tissue without biological relevance, but not in a relevant tissue, would be difficult
to interpret for disease-specific phenotypes. Although other tissues may show same
eQTLs, the retinal effects of eQTLs are more likely to be directly relevant. We
suggest that eQTL analyses of retinal pigment epithelium and choroid would further
contribute to the understanding of genes involved in AMD pathobiology. AMD
associated genes uncovered by TWAS provide additional insights into the relevance
of gene regulation to phenotypic consequences in this complex disease.
EyeGEx complements the GTEx project and provides a reference for the biologi-
cal interpretation of genetic variants associated with common ocular traits, including
glaucoma and diabetic retinopathy. Comparative analysis of retinal transcriptomes
and eQTLs with the GTEx data should assist in exploring biological questions re-
lating to visual function in syndromic and multifactorial traits.
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Chapter 4
Modeling trans-regulatory effect
size distribution using
summary-level data
4.1 Introduction
Genome-wide association studies (GWAs) have been successful in identifying vari-
ants that are implicated in complex traits and diseases. However, most associations
that have been found lie in non-protein coding or intergenic regions of the genome
and so may be involved in the disease process through gene regulation. Hence, a
comprehensive understanding of transcriptome regulation is required to disentangle
the biological mechanisms underlying these associations. This has led to the de-
velopment of approaches based on the integration of both genotype data and gene
expression information to parse out variants involved in gene regulation and how
these variants might affect the disease process. These variants, along with the gene
or genes whose expression they regulate, are known as expression quantitative loci
(eQTLs). These eQTLs can either be cis-acting (affect nearby genes) or trans-acting
(affecting genes distal to the variant).
Recently the GTEx consortium[2] released the 8th version of their analyses where
they identified both cis and trans-eQTLs across 49 tissues with sample sizes from 85
to 706 individuals. While they were able to identify a large number of cis-eQTLs, the
amount of trans-eQTL findings were low across the tissues tested. This low yield of
trans associations- driven by their small effect sizes, the small sample size of current
studies, and the burden of multiple testing for trans-eQTLs-has been observed in
multiple studies[1, 2, 3, 4, 6]. To reduce the burden of multiple testing and so increase
statistical power for trans-eQTL analysis, Westra et al[4] used 4,542 trait-associated
SNPs in a study consisting of 5,311 individuals to identify 346 unique trans acting
variants. More recently, Võsa et al[3] using a similar tactic in a larger study (N =
31,684) and same tissue, focused their trans-eQTL analysis on 10,317 trait-associated
SNPs and discovered a third of these variants having a trans-regulatory effect. These
two studies by dealing with only trait-associated SNPs and tissues such as Whole
Blood-which has a lot of publicly available data- were able to increase their number
of findings for trans-eQTLs.
A recent study[100] formally proposed an ominigenic model to account for the
dispersion of association signals found for complex traits and diseases across the
genome. This model, using the framework of gene-regulatory networks, proposes
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that the genetic contributions to complex traits can be partitioned into direct effect
from sets of core genes and indirect effects from sets of peripheral genes acting in trans
on the set of core genes. Supporting this model are the results found from previous
studies[5, 6, 101, 102, 103, 104] which show that a large proportion of heritability
( 60% - 80%) observed across genes is driven by trans rather than cis effects. These
trans regulatory effects have been shown to be more tissue-specific[1, 3] compared
to cis effects-which tend to be tissue agnostic-and so are likely implicated in the
tissue-specific mechanisms which have an impact on the disease process. However,
the number of discoveries from trans-eQTL studies have been small mainly because
of their small effect sizes, the small sample sizes of current studies, and the issue of
multiple testing[1, 2, 3, 4, 6].
While multiple studies[6, 101, 102, 103, 104] have focused on quantifying the
heritability of gene expression that is due to trans-regulatory effects, no study has
attempted to estimate how polygenic (i.e., the number of loci that contribute to
heritability) trans eQTLs are. In this study, we propose a method that estimates the
average polygenicity and quantifies the distribution of trans-eQTL heritability across
genes. We do this by modeling the effect size distribution of these trans-regulatory
effects across genes. The proposed method extends an earlier approach[105], which
is based on a likelihood framework, to deal with multiple outcomes. In our approach,
we use summary-level data and circumvent issues related to small sample sizes that
are seen in current studies involving trans-eQTLs by marginalizing across genes. In
addition, we developed a computationally efficient approach to summarize the data
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to deal with the large number of marginal effects typically encountered in trans-
eQTL analyses. We show via simulations that the method works, provide a software
implementation, and present results based on our application of the method to GTEx
V8 data for four tissues. Last, we provide estimates of expected yields in future
studies for those tissues.
4.2 Methods
4.2.1 Model
We assume that we have regression coefficients (denoted as β̂(M)) and their standard
errors from the usual marginal model used in eQTL studies. That is, for a given gene,
the regression coefficients and their standard errors are obtained from regressing the
allele count of one SNP at a time on the expression level of the gene. Hence, assuming
we have G genes and a total of K SNPs fitting the trans criteria across all the genes,
we end up with G × K regression coefficients and their respective standard errors.
We assume that these estimates are obtained under the scenario where both the
outcome and the genotype data have been transformed to have unit variance and
mean zero. Let Yg be the expression level of the gth gene, then the polygenic model
for trans eQTLs using this gene can be written Yg =
∑K
i=1Xkβ
(J)
gk + ε. Yg and Xk
are N × 1 vectors of gene expression levels and allelic counts for the gth Gene and
the kth SNP, respectively, across N subjects. Under this approach, we assume that
the distribution of the true effect sizes, based on the joint model, across Kg SNPs
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for gene g are i.i.d according to the following distribution
β
(J)
kg |σ
2
g , πg ∼ πgN (0, σ2g) + (1− πg)δ0 (4.1)
Where both σ2g and πg vary over genes and δ0 is the Dirac delta function indicating
a fraction, 1 − πg, of the SNPs have no effect on the expression level of gene g. We
assume the following distributions for πg and σ
2
g
πg ∼ Beta(α0, β0) and σ2g |πg ∼ Inverse Gamma(a0, b0) (4.2)
set a0 = ν0/2 and b0 = ν0σ
2
0/2. Our goal is to estimate α0, β0, ν0, and σ
2
0.
4.2.2 Composite Likelihood
Given the usual marginal model for trans-eQTLs (I.e, for the kth SNP and gth gene,
Yg = Xkβ
(M)
kg +ε), and utilizing the following relationship between the marginal effect
size, β
(M)
kg , and the joint effect size, β
(J)
kg , for the k
th SNP on the gth gene
β
(M)
kg =
P∑
p=1
β(J)pg ρkp (4.3)
where ρkp is the Pearson correlation coefficient between SNP k and p, it has been
shown [105] that under the assumption of independence between LD patterns and
probability of a SNP having a non-zero effect on gene, the marginal distribution
for β
(M)
kg , for SNP k and gene g, can be approximated with the following mixture
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distribution
β
(M)
kg |πg, σ
2
g ∼
∑
n
(1)
kg
f
N
(1)
kg |πg ,σ2g
(n
(1)
kg )N
(
0,
1∑
h=0
n
(h)
kg
nkg
σ2h,g`kg
)
where n
(0)
kg + n
(1)
kg = nkg, nkg is the observed number of SNPs in the reference panel
that may be ”tagged” by the kth SNP with respect to gene g1, and n
(1)
kg is the observed
number of SNPs, ”tagged” by the kth SNP, with independent non-zero effects on gene
g based on the joint model. f
N
(1)
kg |πg ,σ2g
(n
(1)
kg ) follows a binomial distribution with nkg
number of trials and πg probability of success
f
N
(1)
kg |πg ,σ2g
(n
(1)
kg ) =
nkg!
n
(1)
kg !n
(0)
kg !
π
n
(1)
kg
g (1− πg)n
(0)
kg , n
(1)
kg = 0, . . . , nkg
Then using the fact that conditional on the true marginal effect size the (marginal)
OLS estimate follows a normal distribution, shown below
β̂
(M)
kg |β
(M)
kg ∼ N (β
(M)
kg , a+ s
2
kg)
where the factor ”a” is introduced to account for possible systematic bias in variance
estimates due to effects such as population stratification or cryptic relatedness with
respect to gene g, we obtain the likelihood for β̂
(M)
kg by marginalizing (Appendix C)
1Recall that trans-eVariants have to be a certain distance away from the gene. Hence, for some
SNPs not all variants within its neighborhood will be in Skg. Where Skg is the set of SNPs in the
reference panel that may be ”tagged” by the kth SNP with respect to gene g
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over the distributions of σ2g and πg. This gives us
L(θ, β̂(M)kg ) = f
∗
n
(1)
kg
(0)N
(
0, a+ s2kg
)
+
∑
n
(1)
kg ≥1
f ∗
n
(1)
kg
(n
(1)
kg )Gτkg ,s2kg (σ0, ν0, a) (4.4)
θ = (α0, β0, σ
2
0, ν0, a). f
∗
n
(1)
kg
(n
(1)
kg ) is a beta-binomial distribution with parameters
α0, and β0. N
(
0, a+ s2kg
)
is the distribution obtained when the kth SNP has no
SNP in its neighborhood with a non-zero effect on the gth gene. τkg =
n
(1)
kg
nkg
`kg,
`kg =
∑
p∈Skg ρ
2
kp. I.e., the linkage disequilibrium (LD) score for SNP k with respect
to the set of SNPs, Skg, which it tags in the reference panel and satisfy the trans
criteria for the gth gene. Gτkg ,s2kg (σ0, ν0, a) has a complicated form (Appendix C)
and is the distribution obtained after marginalizing over a Student’s t-distributed
mean parameter in a normal distribution. The likelihood in (4.4) is what is obtained
after averaging over all the possible states for πg, and σ
2
g . Here, πg, and σ
2
g can be
viewed as nuisance parameters which we are not interested in estimating. Ignoring
correlation across genes and between SNPs we use the composite likelihood under a
working independence assumption. This is given as
CL(β̂(M)|θ) =
G∏
g=1
Kg∏
k=1
L(θ, β̂(M)kg ) (4.5)
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Hence the composite log likelihood is
cl(β̂(M)) =
G∑
g=1
Kg∑
k=1
log
f ∗
n
(1)
kg
(0)N
(
0, a+ s2kg
)
+
∑
n
(1)
kg ≥1
f ∗
N
(1)
kg
(n
(1)
kg )Gτkg ,s2kg (σ0, ν0, a)

=
G∑
g=1
Kg∑
k=1
log
(
L(θ, β̂(M)kg )
)
We estimate θ.
Optimization
We can see from (4.5) that the likelihood is maximized over a large set of points.
We reduce the computational load by approximating the distribution of the effect
sizes per SNP across genes. This is done by binning the effect sizes (Appendix C).
This approach is similar to what is done when plotting histograms. We do this for
each SNP using a hundred bins, the same bin width across SNPs, and assigning the
median effect size to all effect sizes that fall in the same bin. Under this paradigm,
and based on 100 bins, (4.5) can be rewritten as
CL(β̂(M)|θ) =
G∏
g=1
Kg∏
k=1
L(θ, β̂(M)kg ) =
K∏
k=1
100∏
r=1
[
L(θ, β̂(M)kr )
]Cr
(4.6)
where Cr is the number of effect sizes that fall within a given bin r.
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4.2.3 Estimation
We use the method of differential evolution[106] to obtain the parameter estimates, θ̂,
which are global maximizers of the composite likelihood in (4.6) with the constraint
that P (h2g ≤ 1) = 1(Appendix C). This constraint ensures that the parameter
estimates, θ̂, are those such that the (unseen) heritability estimates for any gene
in our model cannot be greater than 1. In addition, for each SNP we assumed a
maximum of 5 neighboring SNPs with a non-zero effect on the outcome.
Estimating E(h2g), V ar(h
2
g), E(πg), V ar(πg), E(σ
2
g), and V ar(σ
2
g)
E(πg), V ar(πg), E(σ
2
g), and V ar(σ
2
g) are obtained using the densities in (C.2). With
these we obtain E(h2g), and V ar(h
2
g) as follows (Appendix C).
E(h2g) = E(Mπgσ
2
g) = ME(σ
2
gE(πg|σ2g))
= Mµπµσ2g (4.7)
where µπ = E(πg), µσ2g = E(σ
2
g), and M is the total number of SNPs. The variance
is
V ar(h2g) = V ar(Mπgσ
2
g) = M
2
[
V ar(σ2gE(πg|σ2g)) + E((σ2g)2V ar(πg|σ2g))
]
= M2
[
V ar(σ2g)µ
2
π + E((σ
2
g)
2)V ar(πg)
]
(4.8)
53
4.2.4 Variance calculation
Using the same approach seen in [105, 107] the variance for θ̂ is given as
var(θ̂) = I−1(θ)J(θ)I−1(θ)
where
I(θ) = E
[
G∑
g=1
Kg∑
k=1
Ukg(θ)
∂θ
]
, J(θ) = var
{
G∑
g=1
Kg∑
k=1
Ukg(θ)
}
, Ukg(θ) =
∂
∂θ
log
(
L(θ, β̂(M)kg )
)
We can estimate I(θ) empirically even for correlated data and J(θ) is estimated using
the moving block bootstrap approach (Appendix C). Since, we don’t have θ we use
the plug in estimate θ̂. For the moving block bootstrap approach, we note that the
correlation between the score statistics for any two Genes and SNPs is non-zero if
there is both correlation across Genes for a given SNP and across SNPs for a given
Gene. Hence, we sum the score statistic across Genes for a given SNP, and apply
the moving block approach across SNPs only. This done using overlapping (moving)
blocks of size L-defined as the maximum number of SNPs tagged by any SNP in our
dataset. We then estimate Ĵ(θ̂) as the observed variance in the bootstrap samples.
Based on transforms
Recall that the elements of θ̂ are the parameters for the Beta and the Inverse
Gamma distributions. Using these parameters we can estimate the uncertainty
in the estimates of E(h2g), V ar(h
2
g), E(πg), V ar(πg), E(σ
2
g), and V ar(σ
2
g). This is
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done through two applications of the Delta method (Appendix C). In the first
step, we obtain the covariance matrix for the joint distribution of ξ = g(θ) =(
E(πg), V ar(πg), E(σ
2
g), V ar(σ
2
g)
)
shown below
Σ = g′(θ)var(θ)(g′(θ))T
where g′(θ) is the Jacobian matrix of g(θ) with respect to θ (Appendix C). With
this, the covariance matrix for h(ξ) = (E(h2g), V ar(h
2
g)) is given as
Ξ = h′(ξ)Σ(h′(ξ))T
where h′(ξ) is the Jacobian matrix of h(ξ) with respect to ξ (Appendix C)
4.2.5 Simulation framework
We generate the summary level results using the following model and simulation
scheme. The model used is
β̂
(M)
kg = β
(M)
kg + ξk + ekg
where ξk, k = 1, . . . , K are i.i.d N (0, a), and the error term eg = (e1, . . . , eK) follows
a multivariate normal distribution with mean zero and covariance matrix R/n. R is
a matrix of LD coefficients for the eQTLs of a given gene, and n being the sample
size of the eQTL study with respect to the tissue being used.
The algorith is as follows.
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1. With known values for E(h2g) and E(πg), specify the variance terms (I.e.
V ar(h2g), V ar(πg)) using the coefficient of variation, then derive the correspond-
ing values for E(σ2g), V ar(σ
2
g) using (4.7, 4.8) (Appendix C).
2. Using these values we obtain θ using the method of moments, and generate
πg first then h
2
g (Appendix C). Application of the transformation, σ
2
g =
h2g
Mπg
,
to each sample then gives σ2g , such that the generated πg and σ
2
g follow the
specification in (C.2)
3. Generate β
(J)
kg according to the model in (C.1); from this obtain β
(M)
kg using the
result in (C.3). ρkp, the pairwise Pearson correlation coefficient between mark-
ers k and p, is estimated using the corresponding sample correlation coefficient
in the reference dataset
4. To generate eg note that R will be large and that we also need to account
for the relationship across genes, so we do the following. We note that the
distribution of eg is the same as the joint distribution of the eQTL summary
level statistic under the null of no association between any of the SNPs and the
gene. We also note that there is some correlation of the effect sizes expected
of given SNP across genes, so we do the following.
(a) Using the nref subjects in our 1000 GENOME reference dataset. We
generate, independently, standardized pseudo genes Yi = (Y1, . . . , YG), i =
1, . . . , nref from a multivariate normal distribution. I.e
Yi ∼ MVN(0, V )
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where V can either be estimated from a reference dataset to account for
correlation between the G genes or assumed to be an identity matrix to
represent independence across the G genes.
(b) Using the genotype data in the reference panel, we calculate the standard-
ized effect sizes for a given gene ug = (u1, . . . , uk) for the K SNPs.
(c) Set ekg = ukg
√
nref/n to account for the difference in sample size between
the reference dataset and the eQTL study. Since ug ∼ N (0,R/nref ), then
eg ∼ N (0,R/n)
We sum β
(M)
kg , ξk, ekg and obtain β̂
(M)
kg .
Future projection
With the parameters estimated above, we can provide estimates of the future yield
for other studies using the observed effect sizes. To this end, let NDα be the number
of Gene-SNP associations obtained at the type 1 error rate of α2. Furthermore,
assuming that both the expression levels per Gene and allele count per SNP have
been transformed to have unit variances and mean zero, then using the per Gene
joint effect sizes, β̂
(J)
sg for SNP s and Gene g, we have
E(NDα) ≈ G ∗M
∫
σ2g×πg
∫
β
(J)
sg
powα(β
(J)
sg )p(β
(J)
sg |πg, σ2g)p(πg, σ2g ; θ̂)dβ(J)sg dπgdσ2g
2To account for multiple testing using the Benjamini-Hochberg approach, this is α/(#SNPs ∗
#Genes)
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Where powα(β) = Φ(−zα/2 − β
√
n) + 1 − Φ(zα/2 − β
√
n), Φ(·) is the cumulative
distribution function for the standard normal distribution, zα = Φ(1 − α) is the
αth quantile of the standard normal distribution, and p(β
(J)
sg |πg, σ2g)p(πg, σ2g ; θ̂) is the
inferred effect size distribution for a given gene. Using the normal-mixture model
with the inverse gamma and beta priors per gene, we have the following result after
marginalizing over the gene specific priors
E(NDα) ≈ G ∗M ∗ E(πg)
∫
β
powα(β)t(β;σ0, ν0)dβ.
where t(·) is the generalized student distribution with location parameter zero, scale
parameter σ0, and ν0 degress of freedom.
In a similar vein we obtain the expected value of the proportion of genetic variance
explained by susceptibility SNPs reaching genome-wide significance. After account-
ing for multiple testing and marginalizing over genes, we have
E(GVα) ≈
∫
β
β2powα(β)f(β;σ0, ν0)dβ
where
f(β;σ0, ν0) =
Γ
(
ν0 + 3
2
)
Γ
(ν0
2
)√
2π
(
ν0σ
2
0
2
)ν0/2( 2
x2 + ν0σ20
)(ν0+3)/2
4.2.6 GTEx V8 data
Data generation and processing for the summary level data for the four GTEx tissues
(Skeletal Muscle, Adipose, Testis, and Whole Blood) were described extensively in
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Aguet et al., 2019[2]. Briefly, each SNP and Gene were defined to be in trans distance
of each other if they were on different chromosomes. The covariates in model were
the first five genotype PCs, WGS sequencing platform (HiSeq 2000 or HiSeq X),
WGS library construction protocol (PCR-based or PCR-free), donor sex, and PEER
factors optimized for tissue sample size. Additional quality control for trans-eQTL
mapping involved the removal of any variant with mappability < 1, variants in the
MHC region, variants which are not HapMap 3 SNPs, the exclusion of any gene with
mappability < 0.8, and the removal of any variant-gene pair where the gene cross-
maps with any other gene within 1Mb distance of the variant. Hence we ended up
with summary level data for approximately 1.11 million SNPs across all tissues and
between approximately 17,000 to 24,000 Genes across the four tissues. The effect
sizes for each SNP across Genes were summarized (nbins = 100) using the approach
defined in (4.6).
4.2.7 Estimation of LD-score (`kg) and number of tagged
SNPs (nkg)
The LD score (defined here as the sum of the squared Pearson correlation coefficients
above a given threshold, r2 ≥ ρ, between a given SNP and all SNPs within a window
of ws) and the number of SNPs tagged (here defined as the number SNPs within
the window and having r2 ≥ ρ with the SNP of interest) by each SNP used in our
simulations were obtained using 489 European individuals from the 1000 Genomes
reference panel as described previously[105]. For the GTEx V8 data, `kg and nkg
were estimated using the GCTA software[76]. In both sets ( i.e., simulation datasets
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and GTEx V8 data) of estimates ws = 1Mbps, and ρ = 0.1.
4.3 Results
4.3.1 Simulation studies
Our model consists of five parameters of interest (see Methods). Different combi-
nations of these parameters along with the number of SNPs provide estimates of
six different quantities. These quantities for heritability, polygenicity, and per-SNP
heritability are the averages and the dispersion of each across genes. Implicit in our
estimates is the tissue being used. Hence, for each tissue we may obtain different
results. Of these six quantities, the average heritability (E(h2g)), the dispersion of
heritability across genes (SD(h2g)), and the average polygenicity (E(πg)) are of main
interest since results from our simulations about the remaining parameters were un-
clear. Hence, we treat the remaining three quantities as nuisance parameters which
are needed to provide accurate estimates of E(h2g), SD(h
2
g), and E(πg) but are not of
direct interest to us.
We ran simulations using summary-level statistics while accounting for the LD
patterns observed across SNPs. The summary-level statistics were generated assum-
ing 20,000 genes and using HapMap 3 SNPs with minor allele frequencies (MAF) of
at least 5%. Due to the long computation time of our approach we generated data
using SNPs from either chromosome 22 only (#SNPS = 15,584) or from both chro-
mosome 21 and 22 (#SNPS = 31,195). The result in each scenario in our simulations
is averaged over 50 datasets, and estimation is carried out using 100 bins for each
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dataset. In addition, we assumed that each SNP has maximum of 5 neighbouring
SNPs, on average across genes, with a non-zero effect on the outcome (see Methods).
We first assessed the accuracy of our method under different amounts of average
polygenicity ( E(πg) = 2.5%, and E(πg) = 30%) assuming a small per SNP heri-
tability on average across genes. The average (across genes) per SNP heritability,
E(σ2g), was calculated by first setting E(h
2
g) to 0.12, E(πg) to 30% and assuming we
used a full set of genome-wide SNPs - approximately 1 Million HapMap 3 SNPs at
MAF 5% (see Methods). This produced an average per SNP heritability across genes
as 4e-7 (i.e., E(σ2g) = 4e-7) which was then fixed and used with different amounts
of average polygenicity (E(πg): 2.5%, and 30%) . Hence, the total heritability on
average across genes using SNPs in chromosome 22 only was small (E(h2g)= 1.6e-
4, E(πg) = 2.5%; and E(h
2
g) = 1.9e-3, E(πg) = 30%). With these values, we then
specified the dispersion terms, SD(h2g) and SD(πg), using the coefficient of variation.
This was set to 30%, which reflects a belief of moderate dispersion in relation to the
mean (i.e., E(h2g), and E(πg)). Since E(σ
2
g), and by extension E(h
2
g), was small, this
would mean that we are using SNPs, in chromosome 22 to estimate genome-wide
effects. Hence, we inflated the sample size by a factor of 64 (this roughly equates
to the number of common(MAF≥ 5%) SNPs in HapMap3 divided by the number of
common HapMap3 SNPs in chromosome 22 only) to ensure that we have adequate
power for this set of simulations. Doing this reduced the impact of the residual error
(see Methods). We found that the bias for E(h2g), SD(h
2
g), and E(πg) reduced as the
sample size increased (Figure 4.1).
Next, we assumed that the set of SNPs being used-chromosome 22 SNPs-explained
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Fig. 4.1. Comparison of estimates obtained using averaged across 50 datasets
at a low per SNP heritability (4e-7); We show results based on an average polygenic-
ity of 2.5% (a) and an average polygenicity of 30% (b). Effective sample size is (N ×
#SNPs in Chr 22)/(#SNPs genomewide). Horizontal black lines correspond to the truth. Note
that the y-axis in each subplot are in different scales.
the same amount of variability in the outcome as what we would see if we had used a
full set of genome-wide SNPs instead. Hence, for a given amount of polygenicity, this
corresponds to SNPs in our datasets having a larger effect on the outcome than what
we would realistically see genome-wide. Our results generally remained the same for
E(h2g), SD(h
2
g), and E(πg) when we increased the per-SNP heritability and did not
inflate the sample sizes used in our simulations (Figure C.1). Comparing the main
quantities of interest (E(h2g), SD(h
2
g), and E(πg)) as the average per SNP heritability
increases (5e-5 vs 4e-7), we found that as the average per SNP heritability increases
we obtain better results even after inflating the sample size when the average per
SNP heritability is small (Figure C.2).
We then investigated the effect of increasing the number of SNP used for esti-
mation on the quantities of interest for fixed values of E(h2g), SD(h
2
g) and (E(πg)).
Hence, with these fixed quantities the average per SNP-heritability, E(σ2g), would be
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smaller when we have more SNPs. The comparisons were done using SNPs from
chromosome 22 only and all SNPs from chromosome 21 and 22. We found that with
a larger SNP set, we obtained estimates of SD(h2g) that are less biased (Figure C.3).
To see how our method works as the variability of πg/σ
2
g increases/decreases across
genes, we fixed E(h2g), E(πg), and SD(h
2
g) while we varied the coefficient of variation
for πg from 20% to 80% and ran simulations using chromosome 22 SNPS only. Note
that since E(h2g), E(πg), and SD(h
2
g) are fixed, our results are also equivalent to
decreasing the coefficient of variation for σ2g from 80% to 20% (see Methods). We
saw negligible differences in the mean terms, E(h2g) and E(πg), as the variability of πg
increased across genes (or as the variability of σ2g decreased across genes). However,
the variance of h2g was better estimated when πg varied less across genes (or as σ
2
g
varied more across genes. Figure C.4). Similarly, when we ran simulations allowing
the variability πg and σ
2
g to increase together, we found negligible differences (Figure
C.5) in the estimates for E(h2g) and E(πg) with smaller values of SD(h
2
g) providing
slightly better estimates.
4.3.2 Application to four tissues in GTEx V8
We applied our model, using summary-level results from GTEx V8 data, to four
tissues (Adipose, Testis, Skeletal Muscle and Whole blood) and estimated the trans-
polygenicity and trans-heritability of gene expression. For each tissue, we obtained
summary level results based on trans-eQTL analysis for each tissue as described
previously[2](see Methods). In total we ended up with approximately 1.1 million
SNPs (MAF ≥ 5%) and between approximately 17,000 to 24,000 genes across the
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Fig. 4.2. Results from four GTEx V8 Tissues. (a), A summary of trans-heritability and
trans-polygenicity estimates across genes for each tissue. (b), Boxplots showing the distribution of
trans-heritability across genes for each tissue. The boxplots depict the median, and the lower and
upper hinges correspond to the first and third quartiles, respectively. Outlying data are represented
by individual points that extend beyond 1.5 x interquartile range below the first quartile or above
the third quartile. (c), Projected yield of future studies colored by tissue. These results are based
on power calculations for discovery after Bonferroni correction (P = 2.24 × 10−12) using 20,000
genes and 1.1 million SNPs for all tissues.
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four tissues. The sample sizes per tissue ranged from 322 for Testis to 706 for Muscle.
Across tissues, the estimates for heritability were the highest for Testis and lowest
for Skeletal Muscle. Furthermore, the estimates for the dispersion of heritability
across genes was similar for all tissues except Testis (Figure 4.2a,b). Estimates of
the average polygenicity across tissues (Figure 4.2a) were much higher than what
have been previously reported for complex traits[105, 108]. Projected yields, using
observed effect sizes, of future studies showed patterns consistent with trans-heribility
estimates(Figure 4.2c). In particular, the rate at which the projected number of
discoveries increased as sample size increased was highest for Testis. However, across
all tissues in this study the yields were minimal even at high sample sizes.
Fig. 4.3. Mean heritability of trans-effects across studies. We show barcharts comparing
our estimates to what has been observed. The plot on the left is based on the Adipose tissue, while
the one on the right is based on Whole blood. The colors represent the different technology used
by each study to generate gene expression data.
Comparing our estimates to what is observed in literature, we found that for
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tissues where comparisons exist (Adipose and Whole Blood), our estimates for the
mean heritability were consistently larger (Figure 4.3), regardless of the technology
used to generate the gene expression data and the sample size of the study. Further-
more, consistent with has been reported previously[102], comparisons across different
technologies used in each study to generate the gene expression data showed that
estimates from studies which used rna-seq were consistently higher despite having a
smaller sample size.
4.4 Discussion
In this study we model the effect size distribution of trans effects using a likelihood
framework derived from a two component mixture model. We address the issue of
small sample sizes seen in current studies by marginalizing over genes. We provide
estimates and present summary statistics concerning the distribution of h2g, that are
due to trans regulatory effects, across genes. We show that the estimates can be
quite different across tissues and that our estimates correspond with what have been
reported previously(Figure 4.3)[2, 6, 102]. In addition, we provide estimates of the
average polygenicity across genes for each tissue. Comparison of these estimates
show that relative to complex traits and diseases, trans-regulatory effects are much
more polygenic[105, 108]. However, given that the estimates of the average trans-
eQTL heritability across genes are not too different from that seen for complex traits
and diseases, this implies that the effect sizes for trans-regulatory effects are much
smaller. Coupled with the fact that accounting for multiple testing is a necessity
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in trans-eQTL studies and the relatively small sample sizes of current studies, we
see that at least when compared to complex traits and disease, identification of
trans-eQTLs will be a substantially more difficult task. This conclusion was further
supported when our estimates of yields in future studies were minimal even at large
sample sizes.
Our simulation studies, which were run using small SNP sets because of the
large computational load of our method, displayed patterns that are consistent with
what was seen in a closely related approach[105]. In detail, we obtained estimates
of mean heritability which showed little to no bias as the sample size increased. In
addition, increases in the number of SNPs used for estimation had a negligible im-
pact on the mean terms while decreasing the bais for the dispersion term (Figure
C.3). The remaining parameters, i.e., the dispersion of heritability and the mean
polygenicity, were consistently underestimated across the various simulation scenar-
ios that we used. Some of these results were due to the smaller effect sizes used
which correspond to more realistic scenarios but used only a small subset of SNPs
for estimation. Nevertheless, we observed an improvement in our estimates for given
amounts of polygenicity when the average heritability increased (Figure C.2). Ad-
ditional possible reasons for the underestimation involved 1) assumptions we made
about the number of neighbouring SNPs that have a non-zero effect on the outcome
on average across genes (we assumed that each SNP has a maximum of 5), and 2)
additional biases due to SNPs with small effects being indistinguishable from zero. In
simulations with small SNP sets, we observed that allowing increases in the number
of neighbouring SNPs that have a non-zero effect on the outcome on average across
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genes improved our estimates of polygenicity. However, the bias did not go to zero
and it’s unclear what effect such increases will have when dealing with the full set
of genome-wide SNPs. We hypothesize that some of the current issues are based on
the fact that our model estimates a lot of parameters, some of which may not be
well-identified in our simulations using a limited SNP size.
Comparisons between our results and reported estimates are complicated because
of the different technologies used for gene quantification, the different quality con-
trol measures taken, differences in tissue collection, sampling variation, and other
methodological differences across studies[5, 109]. In spite of this, our estimate for
Whole Blood was similar to a previous result[102] using rna-seq data in the same
tissue. Moreover the pattern of heritability between tissues was consistent with pre-
vious results[103] with the average heritability in the Adipose tissue being larger
than the corresponding estimate in the Whole Blood tissue. Concerning the impact
of technological differences used for gene quantification, Ouwens et al., 2019 showed
that heritability estimates obtained using rna-seq rather than microarray data, in
the same population and tissue, were larger likely because rna-seq is better able to
capture variation in low to moderately expressed genes[102, 110]. While our result for
Whole Blood was larger than the estimate obtained by Ouwens et al., 2019, we note
that the sequencing coverage in GTEx V8 data was much larger (minimum coverage;
50M vs 15M paired end reads). Hence, the resolution of gene-expression in GTEx
V8 rna-seq data is better and likely provides better information about variation in
low to moderately expressed.
Limitations of this study include the choice of r2 threshold and window size used
68
to generate both the LDScores and to specify the number of SNPs tagged for each
SNP. We didn’t investigate this since a previous study[105] using a closely related
method already evaluated the impact of this on the estimated results. Instead, we
used an r2 threshold of 0.1 and a 1 MB window size. A combination which has been
shown to produce estimates of effect-size distributions which are comparable to those
obtained from alternative combinations that are optimal under different scenarios.
For the simulation study, we were limited by the small number of SNPs used for
evaluation. As a result, we weren’t able to evaluate the accuracy of the estimates of
the standard error for each parameter of interest. While our simulation results and
results from a closely related method in another study[105] show that the parameters
(average and dispersion) relating to polygenicity are consistently underestimated, we
argue that the estimates especially that of the average polygenicity still provide a
limited use, and can serve as the lower bound on the average polygenicity of trans-
effects across genes.
Another possible limitation of the proposed method includes the assumption that
effect sizes are independent of allele frequencies and local LD patterns of SNPs. While
it has been shown that this may lead to underestimates of heritability for complex
traits and diseases[111], it’s unclear if this problem will persist when dealing with
gene expression data. In addition, we note that due to the complexity of our model
the average runtime, using 40 CPUs with a total of 30 GB RAM, for one million
SNPs using 100 bins and assuming a maximum of 5 neighbouring SNPs with a non-
zero effect on average on the outcome was between one to two weeks depending on
the tissue of interest.
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In summary, we have developed a method to model the effect size distribution of
trans regulatory effects. We show in simulations that the method works and provide
estimates for four tissues in GTEx V8. Furthermore, we provide a way to estimate
yields in future studies which can then be utilized during the design and planning
phase. While we did not evaluate the accuracy of our method in such scenarios,
we note that the method can easily be adapted to work with summary level data
from any analysis involving multiple phenotypes such as proteomics, metabolomics,
microbiome studies, epigenomics, and other phenome-related approaches. Despite
the limitations in the study, our study advances our understanding of the genetic
architecture of trans-regulatory effects.
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Chapter 5
Conclusions
In this final chapter, we would like to summarize the contributions of this body of
work, and its possible impacts in public health.
5.1 Addressing the bias observed in estimates of
absolute cell fractions using RNA-Seq data
(Chapter 2)
Using several different reference datasets including a bulk/homogenate dataset with
paired DNAm and RNA-seq data from the nucleus accumbens (NAc) from 200+
deceased individuals, we show that RNA-based deconvolution for just two cell pop-
ulations - neurons and non-neurons - largely fails to estimate the underlying cellular
composition of bulk human brain tissue across a variety of algorithms and strategies.
We quantified the diverse range of neuronal fractions estimated by several popular
algorithms to better understand the effects of reference cell type-specific expression
profiles and differences in cell size and/or activity profiles on deconvolution. We
specifically examined the common scenario of performing RNA deconvolution using
cell type-specific reference datasets that can be fundamentally different from user-
provided homogenate tissue target datasets, for example differing in profiled brain
region, sequencing technology and/or cellular compartment. These problems are
likely magnified in human brain tissue compared to suspended cells like blood, where
deconvolution strategies are more easily validated against true cell fractions obtained
by routine complete cell counts[11]. We lastly emphasize caution when performing
RNA-based deconvolution using many cell types ( i.e., more finely-partitioned cell
classes) without having the ability to validate cell counts on at least a subset of
samples. We therefore provide several recommendations for performing RNA-based
deconvolution in bulk human brain gene expression data.
5.2 Integrative analysis using both gene expres-
sion and genetic data to provide valuable in-
sights in the disease progression for Age-related
Macular Degeneration(AMD) (Chapter 3)
Utilizing data from cis regulatory effects in the retina and information about trait-
associated SNPs from AMD GWAs, we were able to connect the lead GWAS signal
to specific target genes at six known AMD loci by multiple lines of evidence. Both
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of the target genes, B3GLCT and BLOC1S1, that were identified by three indepen-
dent methods in our study have been replicated in a related tissue, retinal pigment
epithelium (RPE), as being target genes for AMD[112] . Furthermore, functional
validation experiments in zebrafish, where expression levels for BLOC1S1 were over
expressed led to mild impaired ocular phenotypes[113]. We also showed that even
for a multifactorial disease like AMD with high tissue specificity, variants associ-
ated with gene expression across many tissues as eQTLs, as opposed to those with
tissue-specific associations only, are more likely to show disease association.
5.3 Modeling trans-regulatory effect size distribu-
tion (Chapter 4)
We developed a likelihood framework to estimate the average polygenicity and quan-
tify the distribution of trans-eQTL heritability across genes. We present a software
application and apply the method to summary level data obtained for four tissues
from the Genotype-Tissue Expression(GTEx) Consortium. In addition, we provide
lower bound estimates of the average polygenicity of trans-regulatory effects in these
four tissues, and use results from our model fit to make projections about future stud-
ies. Results from our model are consistent with the current sparsity of trans-eQTL
results.
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Appendix A
Chapter 2
A.1 Sample processing and data generation for
NAc (nucleus accumbens)
Single-nucleus RNA-seq data generation and processing in NAc
We performed single-nucleus RNA-seq (snRNA-seq) on nucleus accumbens (NAc)
tissue from two donors using 10x Genomics Single Cell Gene Expression V3 technol-
ogy. Nuclei were isolated using a Frankenstein nuclei isolation protocol developed
by Martelotto et al. for frozen tissues. Briefly, ∼40mg of frozen NAc tissue was
homogenized in chilled Nuclei EZ Lysis Buffer (MilliporeSigma) in a glass dounce
with ∼15 strokes per pestle. Homogenate was filtered using a 70µm-strainer mesh
and centrifuged at 500xg for 5 minutes at 4°C in a benchtop centrifuge. Nuclei
were resuspended in the EZ lysis buffer, centrifuged again, and equilibrated to nuclei
wash/resuspension buffer (1x PBS, 1% BSA, 0.2U/uL RNase Inhibitor). Nuclei were
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washed and centrifuged in this nuclei wash/resuspension buffer three times, before
labeling with DAPI (10µg/mL). The sample was then filtered through a 35µm-cell
strainer and sorted on a BD FACS Aria II Flow Cytometer (Becton Dickinson) at the
Johns Hopkins University Sidney Kimmel Comprehensive Cancer Center (SKCCC)
Flow Cytometry Core. Gating criteria hierarchically selected for whole, singlet nu-
clei (by forward/side scatter), then for G0/G1 nuclei (by DAPI fluorescence). A null
sort was additionally performed from the same preparation to ensure nuclei input
was free of debris. Approximately 8,500 single nuclei were sorted directly into 25.1µL
of reverse transcription reagents from the 10x Genomics Single Cell 3 Reagents kit
(without enzyme). Libraries were prepared according to manufacturers instructions
(10x Genomics) and sequenced on the Next-seq (Illumina) at the Johns Hopkins
University Transcriptomics and Deep Sequencing Core.
We processed the sequencing data with the 10x Genomics Cell Ranger pipeline,
aligning to the human reference genome GRCh38, with a reconfigured GTF such that
intronic alignments were additionally counted given the nuclear context, to generate
UMI/feature-barcode matrices. We used R package Seurat for raw feature-barcode
quality control, dimensionality reduction (PCA), choosing the top 30 PCs as the
optimal dimensions for clustering. We performed graph-based clustering with the
default Louvain approach, taking a computed K-nearest neighbors graph as input,
which were then annotated with well-established cell type markers for nuclear type
identity. We also used Seurats implementation of non-linear dimensionality reduc-
tion techniques, t-SNE and UMAP, simply for visualization of the high-dimensional
structure in the data, which complemented the clustering results (Figure A.4). With
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the five broad cell type annotations (neurons, oligodendrocytes, oligodendrocyte pre-
cursors, astrocytes, and microglia) of nuclear clusters, we identified unbiased cluster-
driving genes (with Seurats FindAllMarkers() function, using the Wilcoxon rank-sum
test), that were upregulated in each cell type/cluster, compared to all other nuclei.
Using the same set of 24,048 genes, we have 4,169 high-quality nuclei in this refer-
ence, evenly distributed across donors. The top 50- and top 25-per-cell-type gene
sets had 247 and 125 genes, respectively, which included many cell type marker genes
used for annotation.
Bulk NAc Data Generation and Processing
Briefly, the nucleus accumbens (NAc) was dissected under visual guidance using a
hand-held dental drill. Samples were obtained from the ventral striatum, anterior to
the optic chiasm, at the level where the NAcforms a bridge between the putamen and
the head of the caudate. DNA and RNA were concurrently extracted from dissected
tissue using the Qiagen AllPrep DNA/RNA Mini Kit (Cat No./ID: 80204).
NAc DNA was profiled with the Infinium MethylationEPIC microarray using
the manufacturer’s protocol. Raw idat files were processed and normalized using
the minfi Bioconductor package using stratified quantile normalization. Resulting
neuronal fractions were estimated using the minfi estimateCellCounts function us-
ing sorted reference data from the DLPFC for neurons and non-neurons using the
Houseman algorithm.
NAc RNA was subjected to RNA-seq library preparations using the Illumina
RiboZero Gold kits and sequenced using 2x100bp paired end reads on an Illumina
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HiSeq 3000.
A.2 Supplementary Figures
116
Fig. A.1. DNAm estimated neuronal fractions vs PC1. Scatter plot of neuronal fractions
estimated using the Houseman approach with a DNAm reference vs the first principal component
estimated from the bulk RNA-Seq data.
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Fig. A.2. Deconvolution in bulk NAc data using gene expression profiles from the
temporal cortex (Darmanis et al) with cell size estimates derived using mouse samples
(osmFISH estimates of cell size). Scatter plots comparing neuronal fraction estimated for each
individual using DNAm data and the Houseman method vs neuronal fractions based on scRNA-seq
data and estimated using MuSiC with (a) osmFISH cell area as cell size, and (b) osmFISH total
RNA molecule count as cell size.
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Fig. A.3. Neuronal enrichment of gene expression in scRNA-seq from temporal
cortex and snRNA-seq from nucleus accumbens. Scatter plot shows the relationship, based
on log2(fold change) comparing neuronal to glial, between the Darmanis reference dataset (y-axis)
and the NAc reference dataset (x-axis). Each dot represents an estimated log2(fold change) for a
given gene.
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Fig. A.4. t-distributed stochastic neighbor embedding (t-SNE) of single-nucleus
RNA-seq data from the two postmortem NAc samples, representing the 4,169 high-
quality nuclei after processing. Nuclei are colored by cell type annotation after graph-based
clustering, which shown here is largely in agreement with t-SNE coordinates. OPC represents
Oligodendrocyte progenitor cell.
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Appendix B
Chapter 3
B.1 Sample processing and data generation
B.1.1 Tissue, RNA, and DNA preparation
RNA and DNA were isolated from 50-100 mg of homogenized retina tissue in TRIzol®
(Invitrogen, Carlsbad, CA) according to a modified version of the manufacturer’s pro-
tocol that included additional washing steps. The order of extraction was randomized
for all samples. RNA quality and quantity were evaluated using the Bioanalyzer 2100
RNA 6000 Nano assay (Agilent Technologies, Santa Clara, CA). Seven samples with
RIN≤5.0 were excluded from the study. DNA was quantified using the QuantiFluor®
dsDNA System (Promega, Madison, WI).
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RNA library preparation and sequencing
Processing order was randomized before libraries were constructed over two days
largely in batches of 24 or 48 with the TruSeq® Stranded mRNA Library Preparation
Kit (Illumina, San Diego, CA). The DNA concentration of the sequencing library
was determined using the Bioanalyzer DNA 1000 assay (Agilent Technologies, Santa
Clara, CA), and a pool of 12 barcoded libraries were layered on a random selection
of one of the eight lanes of the Illumina flow cell bridge. Paired-end reads of 125 or
126 base pairs were obtained using the HiSeq 2500 platform (Illumina, San Diego,
CA). Sequence data were processed for primary analysis to generate QC values (see
Alignment, QC, and quantification below). Samples with a minimum of 10 million
mapped reads were retained for downstream analysis.
RNA-Seq QC
Of the 523 samples that were sequenced, twenty-six samples were excluded because
of inconsistent or poor subject descriptors as follows: ocular history (1 sample),
ambiguous (1) or missing MGS level (5), age at death < 55 years (7), and RIN <
5.0 (12). Six samples were removed after sequencing since < 10 million reads were
mapped and/or less than 80% of reads aligned to the reference genome, and 10 sam-
ples were eliminated because of skewed gene body coverage over housekeeping genes.
Six samples were taken out due to divergence from European (Caucasian) ancestry.
Discordant CFH and ARMS2 SNP calls between in-house and Michigan genotyping
results were also removed from further analysis (CFH : 1 sample; ARMS2 : 6 sam-
ples). Discordance between nominal gender, genetically inferred gender, and gender
122
inferred from RNA-Seq Principal Component Analysis identified 7 mismatches, and
these samples were not used for further analysis. Thus, a total of 70 unique samples
were removed, and the entire QC process yielded 453 high-quality samples for gene
expression analysis (105 MGS1, 175 MGS2, 112 MGS3, and 61 MGS4).
Alignment, QC, and quantification
Raw RNA-Seq reads were trimmed for Illumina adapters and low quality (SLIDING
WINDOW 4:5; LEADING 5; TRAILING 5; MINLEN 25) in Trimmomatic (version
0.36). QC check was performed using FastQC (version 0.11.5). Trimmed reads were
aligned to the Ensembl release 85 (GRCh38.p7) human genome using STAR (ver-
sion 2.5.2a) with per-sample 2-pass mapping and ENCODE standard options. Ad-
ditional QC metrics were calculated from Trimmomatic, FastQC and STAR using
in-house Python and R scripts, including FASTQ and BAM file sizes, total number
of reads, number of mapped and unmapped reads, and percentage of mapped reads.
RNA-Seq data were also inspected for uniform full-length gene body coverage across
housekeeping genes using RSeQC (version 2.6.4). RSEM (version 1.13.1) was used
to obtain estimated gene- and transcript expression levels. Normalization was per-
formed using Trimmed Mean of M-values (TMM) in Counts per Million (CPM) using
edgeR (version 3.18.1), and then converted into log2 CPM with an offset of 1. For
eQTL analysis, normal quantile transformation was applied instead to log2(CPM)
values. Non-autosomal genes and genes aligning on chromosomal patches/scaffolds
were removed from reference transcriptome and eQTL analyses. Expression of cell-
type specific markers in the retina did not show any significant changes across MGS
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stages, indicating no major loss of cell types during AMD progression (data not
shown).
Reference annotation-based assembly
After individual transcriptomes were assembled using the Reference Annotation-
based Transcript Assembly method within Cufflinks suite (version 2.21), all assem-
blies were merged in Cuffmerge and a single, unique set of assembled transcripts was
generated using Cuffcompare. Over 91% of transcripts in the reference annotation
were captured (196,558 out of 215,929 transcripts), giving a comprehensive general
view of the retina transcriptome. This transcript assembly was then processed using
the following filters to identify putative lincRNA and protein-coding transcripts: (1)
exon count, (2) transcript length, (3) coding potential, (4) functional protein do-
mains, (5) distance to nearest protein-coding gene, and a transcript-level expression
threshold at least 1CPM ≥ 50% of MGS1 controls.
In order to identify lincRNA, multi-exonic transcripts of at least 200 base pairs
were extracted from the transcript assembly. TransDecoder (version 2.0.1) was ap-
plied to select for transcripts with a maximum open-reading frame of 75 amino acids
lacking coding capacity. CPAT (version 1.2.2) was used as a second independent
method to assess coding potential, and only those lincRNA located at least 2 Kb
away from the nearest protein-coding gene were retained. In order to determine
protein-coding transcripts, all multi-exonic transcripts were extracted from the tran-
script assembly. TransDecoder was applied to select for transcripts with a minimum
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open reading frame of 50 amino acid residues of coding capacity, Pfam-based HM-
MER (version 3.1.b) (see URLs) was used to retain transcripts with best 1 domain
e-value of≤0.05 and at least one known functional domain, and CPAT was imple-
mented to further assess coding potential. The logistic regression model and hexamer
table required for CPAT were built using 10,000 coding sequences from the Consensus
Coding Sequence Project and 10,000 annotated noncoding sequences from GenCODE
(release 25). The model was evaluated with 10-fold cross validation. A two-graph
receiver operating characteristic curve was generated to select the optimum coding
probability cutoff value (coding ≥ 0.3755; noncoding < 0.3755).
B.1.2 Genotyping
DNA from 516 samples, along with replicates as QC for 30 random samples, were
genotyped using the UM HUNT Biobank v1.0 chip, which is based on the Illumina
Infinium CoreExome-24 bead array platform (Illumina, San Diego, CA) with 547,655
markers and an additional 55,939 custom content markers. Genotype analysis was
performed with Illumina GenomeStudio (module 1.9.4, algorithm GenTrain 2.0).
We also performed TaqMan SNP genotyping for two variants, in CFH (Y402H;
rs1061170) and ARMS2 (A69S; rs10490924), using the ABI 7900HT sequence detec-
tion system (Applied Biosystems, Foster City, CA). The Y402H variant in CFH was
assayed using a custom-made probe and the A69S variant in ARMS2 was analyzed
using a commercially available TaqMan probe (C 29934973 20). Briefly, 15-30 ng of
DNA was mixed with TaqMan genotyping master mix (Applied Biosystems, Foster
City, CA) and TaqMan SNP genotyping assay mix (40X; Applied Biosystems, Foster
125
City, CA) in a total volume of 15µl. Following PCR, allele discrimination was car-
ried out with the ABI Prism 7900HT genetic detection system (Applied Biosystems,
Foster City, CA).
eQTL QC and imputation
Of the genotyped samples, 20 samples were excluded from analysis: missingness>5%
in 1 sample, relatedness (2nd degree or higher) in 14 samples, and contradictions
in inferred and reported sex in 5 samples. Initial QC at the SNP-level involved
(1) removal of SNPs with HWE P value < 1E-06, (2) call rate < 95%, and (3)
duplicate and non-autosomal variants. We retained 570,441 variants. Genotypes
were imputed with IMPUTE2 based on the 1000 Genomes Project Phase 3 reference
panel (October 2014). For our eQTL analysis, QC after imputation excluded: (1)
poorly imputed variants (info < 0.3), (2) indels of length>51 bp, (3) imputed variants
with HWE < 1E-06, (4) imputed variants with MAF<0.01, and (5) monomorphic
variants. In total, 8,924,684 autosomal variants across 406 individuals were retained,
and coordinates were then converted from Ensembl GRCh 37.p13 to Ensembl GRCh
38.p7 in order to match the retina RNA-Seq data. Population stratification was
examined using Eigenstrat to identify 11 significant principal components; 10 of
these were used in the final eQTL model.
126
B.2 Batch correction
Exclusion criteria for negative control genes in SSVA included: (1) Genes within 100
Kb of linkage disequilibrium of known 34 AMD susceptibility loci identified in the
most recent GWAS study for AMD, (2) RetNet (retinal Information Network) genes
(see URLs), (3) AMD candidate genes from PubMed literature search over the last
five years (see Weighted Gene-correlation Network Analysis in Methods), (4) aging-
and gender-associated genes from GTEx analysis, (5) X and Y chromosomal genes,
and (6) genes that did not meet the expression-level threshold ≥ 1 CPM in ≥ 10%
of all samples.
B.3 eQTL, TWAS, and eCAVIAR
B.3.1 Enrichment
We examined whether there is a broader relationship between cis-eQTLs and AMD
genetic susceptibility beyond what has been observed for known GWAS loci. A Q-Q
plot for each of the GWAS datasets was generated by: (1) subsetting to International
HapMap Project phase 3 (NCBI build 36, dbSNPb129) variants in the European
population with MAF≥0.05, (2) removal of variants in the major histocompatibility
complex region, and (3) removal of variants within ± 1 Mb of the known GWAS
signals. We then stratified the variants into multiple (overlapping) categories based
on eQTL characteristics: (1) retina-specific eQTLs: eVariants that regulate gene
expression only in retina, (2) GTEx-1 eQTLs: eQTLs that regulate gene expression
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in at least 1 GTEx tissue (3) GTEx-20 eQTLs: eQTLs that regulate gene expression
in at least 20 GTEx tissues, and (4) GTEx-40 eQTLs: eQTLs that regulate gene
expression in at least 40 GTEx tissues.
B.3.2 Colocalization
Fine mapping using eCAVIAR was performed in the following manner: (1) for each
lead variant in GWAS, a 1Mb window around it was defined as its locus, (2) for
all variants within the locus, we identified/defined target genes as genes that are
associated at FDR≤0.05 with any of these variants in the eQTL study, and (3) we
calculated the colocalization posterior probability (CLPP) for each variant and target
gene within the loci. The most relevant target gene was then defined as the gene
with the highest CLPP above the threshold of 0.01 within the loci. A maximum of
three possible causal variants for each locus was assumed.
B.3.3 TWAS
The TWAS procedure required that we model gene expression with genotype. The
gene expressions were modeled using either elastic net, mixed models, or least ab-
solute shrinkage and selection operator (LASSO). The LASSO lambda parameter
was calculated using the heritability; genes for which the heritability could not be
calculated used the average heritability across genes instead. Of the 18,053 genes ex-
pressed in the retinal samples, 17,345 were present in the TWAS analysis. Genes not
analyzed in TWAS were located on either sex chromosomes, the mitochondrial chro-
mosome, on scaffolds, or did not have SNPs within 1 Mb of the merged GWAS-eQTL
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SNP set. The mean cross-validated model fit was 0.07, and the mean heritability of
the 14,353 genes for which it could be calculated was 0.127. As expected, the higher
the heritability, the better the cross-validated model fit. LASSO was the best fit
for approximately half of the genes, and elastic net accounted for another quarter;
genes for which the mixed model provided the best fit had models that captured less
variation in expression than other genes.
The TWAS statistics does not take into account LD between genes, so we per-
formed summary-level equivalent conditional tests for each chromosome for genes
that were both significant at an FDR of 0.05 and had a genetic expression model
R2 >than 0.01. Genes were added in a stepwise manner into the model, from lowest
marginal p-value to highest, until no gene remained significant. The model prior
to this saturation was used as the final conditional model; no provision was made
to prevent over-fitting. Of the 61 genes tested, 47 remained nominally significant
at α = 0.05; of these, 39 remained significantly associated after Bonferroni correc-
tion for multiple testing (using all 61 genes considered for the test, not just ones
included in the models). A permutation test (described in Methods) was also per-
formed; seven genes were significant after Bonferroni correction and had a gene model
R2 >0.01, and three of these were outside of the GWAS loci: PARP12, MTMR10,
and SH3BGR.
We explored the tissue specificity of these results, at least in part, using GTEx
data v6. We downloaded the pre-computed TWAS weights derived from the data
of 39 GTEx tissues (excluding cell lines and biological replicate tissues, such as frontal
cortex and cerebellar hemisphere) from the TWAS website (http://gusevlab.org/projects/fusion/)
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and performed the procedure for the GTEx weights with the same set of AMD GWAS
summary statistics that was used with retina. The complete results of the TWAS
analysis - gene model attributes, marginal association statistics, conditional and per-
mutation test results, and GTEx marginal associations for the retinal candidates with
FDR<0.05 - are provided in Supplementary Data S5. Please note that relatively few
genes had weights available in most GTEx tissues.
B.3.4 Evaluation of AMD GWAS lead variants for eQTL
evidence in non-retina tissues
Of the 52 lead variants from AMD-GWAS, 41 were analyzed in our study. Those
not found were either not in the reference dataset used for imputation (6 variants)
or did not pass our MAF threshold (5 variants, MAF threshold; 0.01). Matrix eQTL
was then used to obtain the marginal associations using the same cis criteria, which
were then corrected for multiple testing using the Bonferroni approach at the type I
error rate of 0.05.
We compared our findings to that of Strunz et al. which includes eQTLs from
liver samples of 588 individuals and GTEx (v7). For the Strunz et al. comparison,
we used 31 SNPs with MAF≥ 0.05 that were common to both studies. For each
variant, eQTL analysis was performed for all genes that are present within a 1Mb
window and expressed in the two tissues (Supplementary Data 3). We also tested
37 AMD-associated variants (with MAF≥ 0.01) that were analyzed in the retina
and detected in at least one GTEx (v7) tissue. For each SNP-gene combination,
we list all the GTEx tissues that had p-values less than or equal to that of retina
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(Supplementary Data 3), or if no GTEx tissue had p-value lower than the retina, we
listed all tissues with their respective p-values.
B.4 Gene expression analysis
B.4.1 GSEA
We focused on gene sets that passed a significance threshold of FDR q-value ≤ 0.25
and on key genes that appeared in at least 25% of gene sets in common functional
categories using Leading Edge Analysis (Supplementary Data S6). Comparison of
early AMD to controls identified 38 significantly enriched gene sets, all upregulated
and generally relating to cell killing (3), metabolism (12), and the immune system
(15). The largest of these categories involved immune system processes (13) with an
average normalized enrichment score (avg. NES) of 2.4 and 80 key genes. Compari-
son of intermediate AMD to controls identified 6 upregulated and 60 downregulated
significantly enriched gene sets comprising metabolism (2), cell killing (2), and cellu-
lar component organization (3). Comparison of advanced AMD to controls identified
44 upregulated and 15 downregulated significantly enriched gene sets including those
relating to metabolism (21), cell component organization (9), immune system (6),
and stress response (4). Additionally, we identified downregulated gene sets that
were predominant and largely exclusive to intermediate AMD and associated with
synapses in cell communication (14, avg. NES = -2.2), nervous system development
(9, avg. NES = -2.4), biological regulation (4, avg. NES = -2.3), and establish-
ment/maintenance of cell polarity (3, avg. NES = -2.4) (Supplementary Table S6).
131
B.4.2 Comparison of transcriptomes across retina and GTEx
tissues
The bioinformatics pipeline used to analyze RNA-Seq data in this study mainly dif-
fered from that of GTEx v7 in gene quantification methods and gene annotation
version. To understand the consequences of using different pipelines and to ensure
appropriate tissue comparisons between studies, multidimensional scaling plots and
hierarchical clustering dendrograms were generated based on normalized gene ex-
pression levels from the different pipelines. Statistical methods used to generate
the multi-dimensional scaling (MDS) plot itself were obtained from GTEx. Three
comparisons were made based on the following data sets: (1) Raw GTEx v7 data
processed through our pipeline, (2) Raw GTEx v7 and retina data processed through
our pipeline, and (3) GTEx v7 gene-level TPM count data provided on the GTEx
online portal.
Raw GTEx v7 data were processed through our pipeline as previously mentioned
in 1.2.2 Alignment, QC, and quantification. In addition, we used similar methods
that GTEx had applied to detect samples outliers. PCA-based outlier detection
was performed in the first two principal components by using Mahalanobis distance
to center the data. Outliers were identified using a threshold of three standard
deviations.
B.5 Supplementary Figures and Table
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Fig. B.1. Characteristics of retina donor samples used in this study. a, Violin plots
showing the age distribution, in years, of donors across the four MGS stages. The boxplot within
each violin plot depicts the median, and the lower and upper hinges correspond to the first and third
quartiles, respectively. Outlying data are represented by individual points that extend beyond 1.5
× interquartile range below the first quartile or above the third quartile. The mean age of donors
was 80 years (range 55-107), and the mean donor age increased with AMD severity: 74 years (range
55-94) in MGS1, 78 years (59-101) in MGS2, 84 years (60-98) in MGS3, and 88 years (range 72-107)
in MGS4. b, Distribution of gender across the four MGS stages. Gender was distributed almost
evenly in MGS1 to MGS3, with almost twice as many females as males in MGS4. c, The cause of
death across the four MGS stages. Donors within each MGS stage were grouped into 8 categories
based on the reported cause of death to determine that causes of death were not conflated with
donor age or MGS stage. d, Distribution of post-mortem interval (PMI), in hours. PMI was defined
as the mean time lapse from death to enucleation and tissue cryopreservation. Mean PMI was 18.66
hours. e, Quality of RNA, as defined by the RNA Integrity Number (RIN), used for RNA-Seq.
Mean RIN was 7.42±0.6 (5.1-9). f, Scatterplot of RNA integrity (RIN) versus post-mortem interval
(PMI). g, PCA plots of donors within each MGS level based on normalized gene expression levels.
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Fig. B.2. RNA-Seq QC metrics. a, Number of RNA-Seq reads that mapped to the human
reference genome Ensembl 38.85. The red horizontal line denotes 10 million reads. b, Normalized
mean per-base 5’ to 3’ gene body coverage of housekeeping genes. Left: before outlier removal.
Right: after outlier removal. c, Correlation between 22 significant surrogate variables identified in
SSVA and possible documented sources of variation. A p-value of 0.05 was used as the significance
threshold. Correlation coefficients are labeled in black and color-coded such that positive corre-
lations are displayed in blue and negative correlations in red. Color intensity is proportional to
the correlation coefficients. RIN: RNA Integrity Number; PMI: post-mortem interval. d, Principal
variance component analysis (PVCA) of the retina gene expression data set. Residual represents
the remaining variance in the data set not attributed to the specified batch and biological variables.
Left: before batch correction. Right: after batch correction. RIN: RNA Integrity Number; PMI:
post-mortem interval.
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Fig. B.3. Reference transcriptome of the human retina. a, Gene Ontology (GO) Biologi-
cal Process pathway enrichment analysis of high abundance genes (≥100 FPKM) in the retina. The
bars represent the number of genes identified in each pathway, highlighting in green the number
of inherited retinal disease-causing genes in the RetNet database of ocular diseases (percentage
indicated to the right of bar). Redundancy of enriched GO terms was removed using a similarity
cutoff of 0.40. A Benjamini-Hochberg adjusted p-value≤0.05 was used as the significance threshold.
b, Scatter plot of mitochondrial gene expression based on log2(FPKM+1) values among males and
females. c, Novel transcript discovery using reference annotation-based transcript assembly. Top:
Number of putative novel protein-coding and lincRNA isoforms and transcripts. Bottom: Coding
Potential Assessment Tool (CPAT) coding probability score of putative novel protein-coding and
lincRNA isoforms and transcripts. The dotted red vertical line denotes the calculated coding proba-
bility cutoff of 0.3755. We discovered a total of 410 and 2,861 lincRNA and protein-coding isoforms,
respectively, and a total of 150 and 448 lincRNA and protein-coding transcripts, respectively. d,
Multidimensional scaling plot of samples across tissues based on normalized gene expression levels.
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Fig. B.4. Comparison of RNA-Seq analysis pipelines using GTEx data without retina.
Multidimensional scaling plots and hierarchical clustering dendrograms of samples across tissues
based on normalized gene expression levels. Left: based on our bioinformatics pipeline. Right:
based on GTEx v7 gene-level TPM count data. These comparisons suggest that the relationship
between tissues was not affected by the analysis pipeline.
Our RNA-seq analysis pipeline was based on the most recent literature recommendations for RNA-
Seq analysis (as described in Methods) and mainly differed from that of GTEx in gene quantification
methods and in gene annotation version. We therefore downloaded the raw GTEx data and pro-
cessed these through our bioinformatics pipeline to generate the MDS plot. Statistical methods
used to generate the MDS plot itself were obtained from GTEx. In addition, we explored whether
similar findings could be obtained using a different analysis pipeline. We also plotted MDS plots
from expression data provided on the GTEx online portal. MDS plots and hierarchical clustering
dendrograms generated from different pipelines were comparable.
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Fig. B.5. cis-eQTL analysis. a, The relationship between the strength of each cis-eQTL’s
association and the distance of its eVariant from its eGene’s transcription start site (TSS). b, The
distribution of cis-independent signals for each autosomal gene. Thus approximately 60% of genes
in the retina were found to be under genetic control with the majority of the genes having one
independent signal (41%). c, Distribution of the amount of variability left unexplained in gene
expression levels after correction for other covariates used in the model stratified by the number
of independent signals found per gene. d, Distribution of gene length stratified by the number of
independent signals found per gene. e, Distribution of the amount of variability left unexplained
in gene expression levels after correction for other covariates used in the model ordered by gene
length. f, Proportion of cis-eQTLs discovered in GTEx that were replicated in the retina (y-axis),
ordered by sample size in discovery tissue (x-axis). The color and shape of the points represent the
sample size of the replication tissue. g, Q-Q plot indicating the relationship between the observed
-log10 p-values for each stratum relative to its expected null distribution. Each stratum, except
for the GWAS one, classifies the eVariants by how many tissues they regulate at least one gene in.
This analysis is shown for AMD, schizophrenia, rheumatoid arthritis, and Type 2 diabetes.
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Fig. B.6. Comparison of retina-specific eQTLs across GTEx. a, Boxplots showing
minimum p-values across GTEx tissues for eQTLs detected only in the retina, after correcting for
the number of tissues eQTLs were tested in. As a comparison, distribution of p-values in the retina
analysis for the same eQTLs are also shown. The distribution of p-values between retina and other
tissues is expected given that these SNPs, by definition, are significant eQTLs in retina, but not in
other tissues. b, Median, 75th, and 90th percentile of -log10(p-values) of retina-specific cis-eQTLs
in different non-retina tissues against their respective sample sizes. These plots were generated to
explore whether SNPs that were not detected as significant eQTLs in non-retina tissues using the
stringent p-value threshold could still reveal some enrichment towards lower p-values than what is
expected by chance. We also compared this trend for all eQTLs detected, regardless of whether
they were retina-specific or not. A weak trend towards lower p-values in tissues with large sample
sizes for retina-specific eQTLs was observed. However, this trend was much weaker compared to
that observed for all eQTLs. It appears that retina-specific eQTLs have stronger effects in the
retina though possibility of weak effects of these eQTLs in other tissues cannot be ruled out.
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Fig. B.7. Manhattan plots at known AMD loci. LocusZoom [30] -generated Manhattan
plot of GWAS regions encompassing the candidates that fell within known AMD loci and were shown
to be associated through multiple methods of analysis, as specified by Table 1. The top variants for
the independent eQTL signals determined by the conditional analysis are displayed as diamonds
and labeled. The SNP with the strongest GWAS signal in the region is also identified in each plot.
Coloration of the points is determined by strength of linkage disequilibrium (LD) with respect to
the top variant of the strongest eQTL signal. If LD information provided to LocusZoom was absent
for that SNP, one of its proxies according to LDLink [31] (R2 >0.99) was used. Recombination rate
is shown as a blue line.
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Fig. B.8. Differential expression and WGCNA analysis. a, Heatmap showing the expres-
sion pattern of differentially expressed genes by comparing advanced AMD to controls with and
without adjusting for age at the significance threshold at FDR≤0.20 b, We identified 47 modules,
each containing between 16 and 4,847 genes. Top: Dendrogram of genes with topological overlap
used as distance (shown on y-axis). The color bar below indicates which module the genes belong
to. Bottom: Hierarchical clustering of module expression eigenvalues (eigengenes). The modules
involved in complement (yellow), angiogenesis (light green), immune activation (magenta), and
extracellular matrix (pink) are highlighted in red. These modules were adjacent to each other
according to eigenvalue-based hierarchical clustering. c, Two of these modules were particularly
interesting as they were enriched for literature (pink FDR= 2.21 × 10−3; magenta FDR= 1.37−9)
and leading edge (pink FDR = 1.10 × 10−3; magenta FDR= 1.33 × 10−26) candidate genes. Ad-
ditionally, the magenta module was enriched for genes from the GWAS loci (FDR= 2.38 × 10−4).
The pink module also contained three DE- (FBLN1, MOXD1, IGFBP7) and two AMD-associated
genes (COL8A1 and MMP19). GO analysis of the magenta and pink module highlighted extra-
cellular matrix organization and immune response pathways, respectively, which were previously
implicated in AMD pathology. These modules interacted closely with two other modules; the light
green (also enriched for literature genes, FDR= 8.30× 10−3) and light yellow, which were enriched
for angiogenesis and complement GO terms, respectively. We show only genes that fall in either
literature, GWAS, or differentially expressed groups and are strongly correlated with another such
candidates (adjacency> 0.05).
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Table B.1. Summary of eQTL, eCAVIAR and TWAS analyses for prioritizing vari-
ants and target genes across AMD-GWAS loci.
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Appendix C
Chapter 4
C.1 Definitions/Assumptions
1. We assume the polygenic model for trans-eQTLs. This is written as
Yg = Xβ
(J)
g + ε (C.1)
representing the model for the gth gene. Where Yg is a N × 1 vector of gene
expression levels and X is a N × Kg matrix of genotypes for Kg SNPs across
N subjects. Under this approach, we assume that the distribution of the true
effect sizes, based on the joint model above, across the Kg SNPs for a given
gene, g, are i.i.d according to the following distribution
β
(J)
kg |σ
2
g , πg ∼ πgN (0, σ2g) + (1− πg)δ0 (C.2)
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Where both σ2g and πg vary over genes and δ0 is the Dirac delta function
indicating a fraction, 1−πg, of the SNPs have no association with the expression
level of gene g.
2. The usual marginal model for trans-eQTLs for the kth SNP is written as
Yg = Xkβ
(M)
kg + ε
representing the model for the kth SNP. The true marginal effect size of the k
SNPs on the gth gene is related to its joint effect on the same gene accounting
for the other snps in the model by the following relationship (for clarity, we
omit the notation g, and note that each snp effect is gene specific so that the
form below depends on SNPs fitted for the same gene)
β
(M)
k =
P∑
p=1
β(J)p ρkp (C.3)
where ρkp is the Pearson correlation coefficient between SNP k and p.
3. Conditional on the true marginal effect size the (marginal) OLS estimate follows
a normal distribution, shown below
β̂
(M)
kg |β
(M)
kg ∼ N (β
(M)
kg , a+ s
2
kg)
where the factor ”a” is introduced to account for possible systematic bias in
variance estimates due to effects such as population stratification or cryptic
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relatedness with respect to gene g.
4. We place the following priors on πg and σ
2
g .
πg ∼ Beta(α0, β0) and σ2g |πg ∼ Inverse Gamma(a0, b0)
set a0 = ν0/2 and b0 = ν0σ
2
0/2.
5. In general if X|σ2 ∼ N (0, κσ2) and σ2 ∼ Inverse Gamma (a0, b0), where a =
ν0/2 and b0 = ν0σ
2
0/2, then X has the Student-t marginal distribution shown
below
Γ
(
ν0 + 1
2
)
Γ
(ν0
2
)√
κν0σ20π
(
1 +
1
κν0
[
x
σ0
]2)−ν0 + 12

6. Let Y |µ ∼ N (µ, σ2) and µ be t-distributed with location parameter zero
and scale parameter k with ν degrees of freedom, then the distribution of
Y marginalized over µ is given as
fY (y) =
exp
(
− y
2
2σ2
)
Γ
(ν
2
)√
πνk2
(
νk2
2σ2
)ν + 1
2
 ∫ ∞
0
t[(ν+1)/2]−1√
1 + t
exp
(
1
2σ2
[
y2
1 + t
− tνk2
])
dt
and can be simplified to give
fY (y) =
exp
(
− y
2
2σ2
)
Γ
(ν
2
)√
2πσ2
(
νk2
2σ2
)ν/2
Γ
(
ν + 1
2
) ∞∑
i=0
1
i!
(
y2
2σ2
)i
· U
(
ν + 1
2
,
ν
2
+ 1− i, νk
2
2σ2
)
Where U(a,b,z) is Tricomi’s (confluent hypergeometric) function and is defined
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as
U(a, b, z) =
1
Γ(a)
∫ ∞
0
exp(−zt)ta−1(1 + t)b−a−1 dt, (Re a > 0 )
C.2 Results
1. Let Skg represent the set of SNPs in the reference panel that may be ”tagged”
by the kth SNP with respect to gene g1. Define Nkg = |Skg| as the number of
SNPs in Skg, and N (1)kg as the number of SNPs in Skg with non-zero effects on
gene g based on the joint model. Furthermore, let `kg =
∑
p∈Skg ρ
2
kp. I.e., the
linkage disequilibrium (LD) score for SNP k with respect to the set of SNPs in
Skg. We have from [105] that under the assumption of independence between
LD patterns and probability of a SNP having a non-zero effect on gene, the
marginal distribution for β
(M)
kg , for SNP k and gene g, is given as
β
(M)
kg |πg, σ
2
g ∼
∑
n
(1)
kg
f
N
(1)
kg |πg ,σ2g
(n
(1)
kg )N
(
0,
1∑
h=0
n
(h)
kg
nkg
σ2h,g`kg
)
(C.4)
where n
(0)
kg + n
(1)
kg = nkg, the observed Nkg
f
N
(1)
kg |πg ,σ2g
(n
(1)
kg ) =
nkg!
n
(1)
kg !n
(0)
kg !
π
n
(1)
kg
g (1− πg)n
(0)
kg , n
(1)
kg = 0, . . . , nkg
1Recall that trans-eVariants have to be a certain distance away from the gene. Hence, for some
SNPs not all variants within its neighborhood will be in Skg
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Furthermore, from [105] we have that
β̂
(M)
kg |πg, σ
2
g ∼
∑
n
(1)
kg
f
N
(1)
kg |πg ,σ2g
(n
(1)
kg )N
(
0,
1∑
h=0
n
(h)
kg
nkg
σ2h,g`kg + a+ s
2
kg
)
(C.5)
The goal is to obtain the unconditional distribution of β̂
(M)
kg with respect to σ
2
g
and πg. Hence (C.5) can be rewritten as
β̂
(M)
kg |πg, σ
2
g ∼ fN(1)kg |πg ,σ2g(0)N
(
0, a+ s2kg
)
+
∑
n
(1)
kg =1
f
N
(1)
kg |πg ,σ2g
(n
(1)
kg )N
(
0,
1∑
h=0
n
(h)
kg
nkg
σ2h,g`kg + a+ s
2
kg
)
(C.6)
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Case 1; n
(1)
kg ≥ 1
We have
∫
πg
∫
σ2g
(
β̂
(M)
kg |πg, σ
2
g
)
fσ2g ,πg(σ
2
g , πg) =
∫
πg
∫
σ2g
 ∑
n
(1)
kg =1
f
N
(1)
kg |πg
(n
(1)
kg ) ×
N
(
0,
1∑
h=0
n
(h)
kg
nkg
σ2h,g`kg + a+ s
2
kg
)]
fσ2g ,πg(σ
2
g , πg)
=
∫
πg
∫
σ2g
 ∑
n
(1)
kg =1
f
N
(1)
kg |πg
(n
(1)
kg )×
∫
β
(M)
kg
f
β̂
(M)
kg |β
(M)
kg
(
β̂
(M)
kg
)
f
β
(M)
kg |σ2g
(
β
(M)
kg
)]
fσ2g ,πg(σ
2
g , πg)
=
∑
n
(1)
kg =1
∫
β
(M)
kg
∫
πg
∫
σ2g
f
N
(1)
kg |πg
(n
(1)
kg )fβ̂(M)kg |β
(M)
kg
(
β̂
(M)
kg
)
×
f
β
(M)
kg |σ2g
(
β
(M)
kg
)
fσ2g ,πg(σ
2
g , πg)
The last line is as a result of the Fubini-Tonelli theorem. Therefore we proceed
as follows.
2. Using eqn C.4 and definition (5) we have the unconditional distribution for
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β
(M)
kg , with respect to σ
2
g , as
β
(M)
kg |πg ∼
∑
n
(1)
kg
f
N
(1)
kg |πg
(n
(1)
kg )Dτkg (σ0, ν0) (C.7)
where
Dτkg (σ0, ν0) =
Γ
(
ν0 + 1
2
)
Γ
(ν0
2
)√
ν0τkgσ20π
1 + 1
ν0
[
β
(M)
kg
σ0
√
τkg
]2−
ν0 + 1
2

and τkg =
n
(1)
kg
nkg
`kg. I.e., Dτkg (σ0, ν0) is a generalized t distribution with mean 0
for ν0 > 1, and variance τkgσ
2
0
ν0
ν0 − 2
for ν0 > 2.
3. From eqn (C.7) the unconditional distribution with respect to πg is then
β
(M)
kg ∼
∑
n
(1)
kg
f ∗
N
(1)
kg
(n
(1)
kg )Dτkg (σ0, ν0) (C.8)
where
f ∗
N
(1)
kg
(n
(1)
kg ) =
(
nkg
n
(1)
kg
)
B((α0 + n
(1)
kg ), (β0 + n
(0)
kg ))
B(α0, β0)
=
1
(nkg + 1)
1
B((n
(0)
kg + 1), (n
(1)
kg + 1))
B((α0 + n
(1)
kg ), (β0 + n
(0)
kg ))
B(α0, β0)
I.e., the Beta-binomial distribution.
4. Set θ = (a, α0, β0, σ0, ν0), then from (C.8), (3) and (6), we have the marginal
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distribution of β̂
(M)
kg as
β̂
(M)
kg |θ ∼
∑
n
(1)
kg
f ∗
n
(1)
kg
(n
(1)
kg )Gτkg ,s2kg (σ0, ν0, a) (C.9)
where Gτkg ,s2kg (σ0, ν0, a) has the form given in (6) and shown below
exp
(
−
(β̂
(M)
kg )
2
2(a+ s2kg)
)
Γ
(ν0
2
)√
2π(a+ s2kg)
(
ν0σ
2
0τkg
2(a+ s2kg)
)ν0/2
Γ
(
ν0 + 1
2
)
×
∞∑
i=0
1
i!
(
(β̂
(M)
kg )
2
2(a+ s2kg)
)i
· U
(
ν0 + 1
2
,
ν0
2
+ 1− i, ν0σ
2
0τkg
2(a+ s2kg)
)
and τkg =
n
(1)
kg
nkg
`kg.
Case 2; n
(1)
kg = 0
Here
∫
πg
∫
σ2g
(
β̂
(M)
kg |πg, σ
2
g
)
fσ2g ,πg(σ
2
g , πg) =
∫
πg
∫
σ2g
[
f
N
(1)
kg |πg
(0)N
(
0, a+ s2kg
)]
fσ2g ,πg(σ
2
g , πg)
=
∫
πg
[
f
N
(1)
kg |πg
(0)N
(
0, a+ s2kg
)]
fπg(πg)
= f ∗
n
(1)
kg
(0)N
(
0, a+ s2kg
)
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Hence the likelihood for snp k with respect to gene g is
L(θ, β̂(M)kg ) = f
∗
n
(1)
kg
(0)N
(
0, a+ s2kg
)
+
∑
n
(1)
kg ≥1
f ∗
n
(1)
kg
(n
(1)
kg )Gτkg ,s2kg (σ0, ν0, a)
note that
E(β̂
(M)
kg ) = 0 and Var(β̂
(M)
kg ) = a+ s
2
kg + τkgσ
2
0
ν0
ν0 − 2
for ν0 > 2
5. Ignoring correlation across genes and between snps we use the composite like-
lihood under a working independence assumption. This is given as
CL(β̂(M)|θ) =
G∏
g=1
Kg∏
k=1
L(θ, β̂(M)kg ) (C.10)
Hence the composite log likelihood is given as
cl(β̂(M)) =
G∑
g=1
Kg∑
k=1
log
f ∗
n
(1)
kg
(0)N
(
0, a+ s2kg
)
+
∑
n
(1)
kg ≥1
f ∗
N
(1)
kg
(n
(1)
kg )Gτkg ,s2kg (σ0, ν0, a)

=
G∑
g=1
Kg∑
k=1
log
(
L(θ, β̂(M)kg )
)
We estimate 5 parameters, I.e., θ = (α0, β0, σ0, ν0, a).
150
Optimization
We can see from (C.8) that the likelihood is maximized over a large set of
points. To optimize this, we propose the following simplifications using a sieve
approach.
We partition the likelihood over the genome by defining neighboring disjoint
sets Sr, r = 1 . . . , R such that
L(θ, β̂(M)kg ) = L(θ, β̂
(M)
kr ) for all g ∈ Sr
Let Cr = |Sr|, that is, Cr is the number of elements in Sr and note that Sr is
defined so that
∑R
r=1 |Sr| =
∑R
r=1Cr = G. For each set, Sr, we define β̂
(M)
kr
such that2
∑
g∈Sr I(β̂
(M)
kg ≤ β̂
(M)
kr )
Cr
=
∑
g∈Sr I(β̂
(M)
kg > β̂
(M)
kr )
Cr
= .5
Hence (C.8) is rewritten as
CL(β̂(M)|θ) =
G∏
g=1
Kg∏
k=1
L(θ, β̂(M)kg ) =
K∏
k=1
R∏
r=1
[
L(θ, β̂(M)kr )
]Cr
(C.11)
If R = G, I.e., each set contains only one gene, then we obtain (C.8). We can
choose R such that R G.
2Note that this is done on a per SNP basis. I.e., k is fixed.
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Estimation
We use the method of differential evolution[106] to obtain the parameter esti-
mates, θ̂, which are global maximizers of the composite log-likelihood with the
constraint that P (h2g ≤ 1) = 1. The reason for this is as follows. Assuming that
the gth gene and all the M SNPs in the genotype matrix for the joint model
(eqn C.1) have been transformed to have unit variances and mean zero then
h2g =
M∑
k=1
V ar(β
(J)
kg ) = Mπgσ
2
g
Based on our specification for the distributions of πg and σ
2
g in (4) we have
that
h2g|M,πg ∼ Inverse Gamma(a0,Mπgb0)
Hence the density for h2g in our model is
f(h2g;θ) =
∫ 1
0
f(h2g|πg; ν0, σ20)f(πg;α0, β0) dπg, 0 ≤ h2g <∞ (C.12)
So that based on our model h2g can be greater than 1. To remedy this, we
require that 0 ≤ h2g ≤ 1 for all genes. Hence, since h21, . . . , h2G are iid from
the density in (C.12), an equivalent requirement is
∏G
g=1 P (h
2
g ≤ 1) = 1 or
P (h2g ≤ 1) = 1 for any gene g. Where
P (h2g ≤ 1) =
∫ 1
0
f(h2g;θ) dh
2
g
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Since P (h2g ≤ 1) < 1 implies that given parameter values θ there exists some
genes with h2g > 1 which is not possible.
Estimating E(h2g), V ar(h
2
g), E(πg), V ar(πg), E(σ
2
g), and V ar(σ
2
g)
Recall that the elements of θ̂ are the paramters for the beta and the inverse
gamma distributions. Hence
V ar(β
(J)
kg ) = πgσ
2
g
is the per SNP heritability for gene g. Hence, the total narrow sense heritability
(assuming Yg is scaled to have unit variance) for gene g is
h2g =
M∑
k=1
V ar(β
(J)
kg ) = Mπgσ
2
g
With this in mind we can specify the average heritability and its variance across
genes and use this as follows.
E(h2g) = E(Mπgσ
2
g) = ME(σ
2
gE(πg|σ2g))
= MµπE(σ
2
g)
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where µπ = E(πg). Where M is the total number of SNPs, and the variance
V ar(h2g) = V ar(Mπgσ
2
g) = M
2
[
V ar(σ2gE(πg|σ2g)) + E((σ2g)2V ar(πg|σ2g))
]
= M2
[
V ar(σ2g)µ
2
π + E((σ
2
g)
2)V ar(πg)
]
Where E(πg), V ar(πg), E(σ
2
g), and V ar(σ
2
g) are obtained using the densities in
(4)
Variance calculation
Using the same approach seen in [105, 107] the variance for θ̂ is given as
var(θ̂) = I−1(θ)J(θ)I−1(θ)
where
I(θ) = E
[
G∑
g=1
Kg∑
k=1
Ukg(θ)
∂θ
]
, J(θ) = var
{
G∑
g=1
Kg∑
k=1
Ukg(θ)
}
, Ukg(θ) =
∂
∂θ
log
(
L(θ, β̂(M)kg )
)
We can estimate I(θ) empirically even for correlated data. Hence for I(θ) its
empirical estimate at the true value is
Î(θ) =
G∑
g=1
Kg∑
k=1
Ukg
∂θ
=
G∑
g=1
Kg∑
k=1
lkg(θ)
∂θ∂θT
lkg(θ) = log
(
L(θ, β̂(M)kg )
)
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Doing the same for J(θ) we have its empirical variance estimate at the truth
as
Ĵ(θ) = Var
(
G∑
g=1
Kg∑
k=1
Ukg(θ)
)
Both estimates would be consistent. However, we don’t have θ so we use the
plug in estimate θ̂, so that
Î(θ̂) =
G∑
g=1
Kg∑
k=1
lkg(θ)
∂θ∂θT
∣∣∣∣
θ=ˆθ
Ĵ(θ̂) = Var
(
G∑
g=1
Kg∑
k=1
Ukg(θ̂)
)
= E
{ G∑
g=1
Kg∑
k=1
Ukg(θ̂)
}{
G∑
g=1
Kg∑
k=1
Ukg(θ̂)
}T
We can rewrite the last equation as
E
{ G∑
g=1
Kg∑
k=1
Ukg(θ̂)
}{
G∑
g=1
Kg∑
k=1
Ukg(θ̂)
}T = E( N∑
i,j,m,n=1
Ukgi,m(θ̂)Ukgj,n(θ̂)
T
)
Where N =
∑G
g=1Kg is the total number of SNP × Gene trans pairs. Hence,
we see that estimating Ĵ(θ̂) is computationally intensive. To address this we
utilize the moving block bootstrap approach. We observe that the correlation
between the score statistics for any two Genes and SNPs is non-zero if there
is both correlation across Genes for a given SNP and across SNPs for a given
Gene. Hence, we sum the score statistic across Genes for a given SNP, and
apply the moving block approach across SNPs only. We construct overlapping
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(moving) blocks of size L. For each block, we sum across SNPs that fall within
it, then sum the results across all blocks. The bootstrap approach is due to
the fact that we change the starting point of the moving blocks for each of
the B bootstrap samples. The block window size is selected by choosing the
maximum number of SNPs tagged by any SNP genome-wide. We then estimate
Ĵ(θ̂) as the observed variance in the bootstrap samples.
Based on transforms
Recall that the elements of θ̂ are the parameters for the Beta and the Inverse
Gamma distributions. Using these parameters we can estimate the uncertainty
in the estimates of E(h2g), V ar(h
2
g), E(πg), V ar(πg), E(σ
2
g), and V ar(σ
2
g). This
is done through two applications of the Delta method. Define
g(θ) =
(
E(πg) V ar(πg) E(σ
2
g) V ar(σ
2
g)
)
Hence g(·) is a function of α0, β0, ν0, and σ20. Hence the covariance matrix for
the joint distribution of E(πg), V ar(πg), E(σ
2
g), and V ar(σ
2
g) is
Σ = g′(θ)var(θ)(g′(θ))T
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where
g′(θ) =

∂E(πg)
∂α0
∂E(πg)
∂β0
∂E(πg)
∂ν0
∂E(πg)
∂σ20
∂V ar(πg)
∂α0
∂V ar(πg)
∂β0
∂V ar(πg)
∂ν0
∂V ar(πg)
∂σ20
∂E(σ2g)
∂α0
∂E(σ2g)
∂β0
∂E(σ2g)
∂ν0
∂E(σ2g)
∂σ20
∂V ar(σ2g)
∂α0
∂V ar(σ2g)
∂β0
∂V ar(σ2g)
∂ν0
∂V ar(σ2g)
∂σ20

With this we can then obtain the covariance matrix for E(h2g), and V ar(h
2
g).
Let
ξ = g(θ) =
(
µπg τπg µσ2g τσ2g
)
where µπg , τπg , µσ2g , and τσ2g represent E(πg), V ar(πg), E(σ
2
g), and V ar(σ
2
g) re-
spectively using θ. Furthermore, let
h(ξ) = (E(h2g) V ar(h
2
g))
Hence the covariance matrix for E(h2g), and V ar(h
2
g) is
Ξ = h′(ξ)Σ(h′(ξ))T
where
h′(ξ) =

∂E(h2g)
∂µπg
∂E(h2g)
∂τπg
∂E(h2g)
∂µσ2g
∂E(h2g)
∂τσ2g
∂V ar(h2g)
∂µπg
∂V ar(h2g)
∂τπg
∂V ar(h2g)
∂µσ2g
∂V ar(h2g)
∂τσ2g

157
C.3 Simulation approach
We generate the summary level results using the following model and simulation
scheme. The model used is
β̂
(M)
kg = β
(M)
kg + ξk + ekg
where ξk, k = 1, . . . , K are i.i.d N (0, a), and the error term eg = (e1, . . . , eK) follows
a multivariate normal distribution with mean zero and covariance matrix R/n. R is
a matrix of LD coefficients for the eQTLs of a given gene, and n being the sample
size of the eQTL study with respect to the tissue being used.
For each simulation, we first generate πg and σ
2
g for gene g according to (4) using
pre-specified values of α0, β0, ν0 and σ
2
0. We then generate β
(J)
kg according to the model
in (C.2); from this obtain β
(M)
kg using the result in (C.3). ρkp, the pairwise Pearson
correlation coefficient between markers k and p, is estimated using the corresponding
sample correlation coefficient in the reference dataset.
To generate eg note that R will be large and that we also need to account for the
relationship across genes, so we do the following. We note that the distribution of
eg is the same as the joint distribution of the eQTL summary level statistic under
the null of no association between any of the SNPs and the gene. We also note that
there is some correlation of the effect sizes expected of given SNP across genes, so
we do the following.
1. Using the nref subjects in our 1000 GENOME reference dataset. We generate,
independently, standardized pseudo genes Yi = (Y1, . . . , YG), i = 1, . . . , nref
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from a multivariate normal distribution. I.e
Yi ∼ MVN(0, V )
where V can either be estimated from a reference dataset to account for corre-
lation between the G genes or assumed to be an identity matrix to represent
independence across the G genes.
2. Using the genotype data in the reference panel, we calculate the standardized
effect sizes for a given gene ug = (u1, . . . , uk) for the K SNPs.
3. Set ekg = ukg
√
nref/n to account for the difference in sample size between
the reference dataset and the eQTL study. Since ug ∼ N (0,R/nref ), then
eg ∼ N (0,R/n)
Addendum
We use the following transformation
σ2g =
h2g
Mπg
this implies that the distribution of h2g|πg as
h2g|πg ∼ Inv-Gamma(a,Mπgb)
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Hence, we generate πg first then using this as well the number of SNPs we then
generate h2g from the distribution above. Using the transformation
σ2g =
h2g
Mπg
we obtain σ2g , with each following the specification in (4).
C.4 Future projection
OWith the parameters estimated above, we can provide estimates of the future yield
for other studies using the observed effect sizes. Let NDα be the number of Gene-
SNP associations obtained at the type 1 error rate of α3. Furthermore, assuming that
both the expression levels per Gene and allele count per SNP have been transformed
to have unit variances and mean zero, then using the per Gene joint effect sizes, β̂
(J)
sg
for SNP s and Gene g, we have
E(NDα) = E(E(NDα|Gene))
=
G∑
g=1
M∑
s=1
P
(√
n | β̂(J)sg |> zα/2
∣∣β(J)sg )
≈ G ∗M
∫
σ2g×πg
∫
β
(J)
sg
powα(β
(J)
sg )p(β
(J)
sg |πg, σ2g)p(πg, σ2g ; θ̂)dβ(J)sg dπgdσ2g
3To account for multiple testing using the Benjamini-Hochberg approach, this is α/(#SNPs ∗
#Genes)
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Where powα(β) = Φ(−zα/2 − β
√
n) + 1 − Φ(zα/2 − β
√
n), Φ(·) is cumulative dis-
tribution function for the standard normal distribution, zα = Φ(1 − α) is the αth
quantile of the standard normal distribution, and p(β
(J)
sg |πg, σ2g)p(πg, σ2g ; θ̂) is the in-
ferred effect size distribution for a given gene. Using the normal-mixture model
with the inverse gamma and beta priors per gene, we have the following result after
marginalizing over the gene specific priors
E(NDα) ≈ G ∗M ∗ E(πg)
∫
β
powα(β)t(β;σ0, ν0)dβ.
where t(·) is the generalized student distribution with location parameter zero, scale
parameter σ0, and ν0 degress of freedom.
In a similar vein we can obtain the expected value of the proportion of genetic
variance explained by susceptibility SNPs reaching genome-wide significance, after
accounting for multiple testing and averaged across genes, as
E(GVα) = E(E(GVα|Gene))
≈
∫
σ2g
σ2g
∫
β
β2powα(β)N (0, σ2g)p(σ2g)dβdσ2g
This can be simplified as
E(GVα) ≈
∫
β
β2powα(β)f(β;σ0, ν0)dβ
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where
f(β;σ0, ν0) =
Γ
(
ν0 + 3
2
)
Γ
(ν0
2
)√
2π
(
ν0σ
2
0
2
)ν0/2( 2
x2 + ν0σ20
)(ν0+3)/2
C.5 Derivations
1. Show
β
(M)
k =
P∑
p=1
β(J)p ρkp
where ρkp is the correlation coefficient between snps k and p.
Under the polygenic model for the gth gene expression level we have
Yg = Xβ
(J) + ε
where Yg is a n × 1 vector of gene expression levels and X is the n × P matrix
of genotypes for P SNPs and n subjects. Furthermore, assume that both Yg
and X have both been transformed to have a sample variance of 1 and a sample
mean of 0. Then the OLS estimate, β̂
(M)
k , for the k
th snp is derived as
β̂
(M)
k = (X
T
k Xk)
−1XTk Yg =
1
n
XTk Yg
This can be further simplified based on the polygenic model as
β̂
(M)
k =
1
n
XTk (Xβ̂
(J) + ε) =
1
n
P∑
p=1
XTk Xpβ̂
(J)
p + 0
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since the columns of X are transformed to have sample variances of 1 and
sample means of 0, then XTk Xp = nρkp. Furthermore X
T
k ε = 0 since Xk is in
the column space of X.
2. Let Y |µ ∼ N (µ, σ2) and µ be t-distributed with location parameter zero
and scale parameter k with ν degrees of freedom, then the distribution of
Y marginalized over µ is given as
fY (y) =
exp
(
− y
2
2σ2
)
Γ
(ν
2
)√
2πσ2
(
νk2
2σ2
)ν/2
exp
(
νk2
2σ2
)∫ ∞
1
q
−
1
2 (q − 1)(ν−1)/2 exp
(
1
2σ2
[
y2
q
− qνk2
])
dq
Derivation
Recall that
Γ(s) =
∫ ∞
0
ts−1 exp(−t) dt
Hence
Γ
(
ν + 1
2
)(
1 +
1
ν
[µ
k
]2)−ν + 12

=
∫ ∞
0
w
ν + 1
2
−1
exp
(
−w
[
1 +
1
ν
(µ
k
)2])
dw (A)
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Therefore
fY (y) =
∫ ∞
−∞
fY |µ(y) · fµ(µ) dµ
=
∫ ∞
−∞
exp
(
−(y − µ)
2
2σ2
)
√
2πσ2
·
Γ
(
ν + 1
2
)
Γ
(ν
2
)√
πk2ν
(
1 +
1
ν
(µ
k
)2)−ν + 12

dµ
=
1
Γ
(ν
2
)√
πνk2
∫ ∞
−∞
exp
(
−1
2
[
y − µ
σ
]2)
√
2πσ2
×
∫ ∞
0
w
ν + 1
2
−1
exp
(
−w
[
1 +
1
ν
(µ
k
)2])
dwdµ From (A)
This simplifies to
exp
(
− y
2
2σ2
)
Γ
(ν
2
)√
πνk2
∫ ∞
0
(
1 +
2wσ2
νk2
)−1/2
w
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2
−1
exp(−w) exp
(
y2
2σ2
[
1 +
2wσ2
νk2
]−1)
dw (B)
setting q = 1 +
2wσ2
νk2
, (B) becomes
fY (y) =
exp
(
− y
2
2σ2
)
Γ
(ν
2
)√
2πσ2
(
νk2
2σ2
)ν/2
exp
(
νk
2σ2
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1
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2 (q−1)(ν−1)/2 exp
(
1
2σ2
[
y2
q
− qνk2
])
dq
For a specific value of ν, we obtain the form given in 6. More generally, if we
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use the transformation t =
2wσ2
νk2
instead, we have (B) simplifying as
fY (y) =
exp
(
− y
2
2σ2
)
Γ
(ν
2
)√
πνk2
(
νk2
2σ2
)ν + 1
2
 ∫ ∞
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1 + t
exp
(
1
2σ2
[
y2
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(C.13)
Simplifying the integral we have
∫ ∞
0
t[(ν+1)/2]−1√
1 + t
exp
(
1
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[
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1 + t
− tνk2
])
dt =
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1 + t
exp
(
−tνk
2
2σ2
)
×
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i=0
(
y2
2σ2(1 + t)
)i
/i! dt
Recall that Tricomi’s (confluent hypergeometric) function, U(a,b,z) is given as
U(a, b, z) =
1
Γ(a)
∫ ∞
0
exp(−zt)ta−1(1 + t)b−a−1 dt, (Re a > 0 )
Setting a =
ν + 1
2
, b =
ν
2
+ 1− i, and z = νk
2
2σ2
we have
∫ ∞
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)
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Hence,
fY (y) =
exp
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− y
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Furthermore, from (B) we have
∫ ∞
−∞
fY (y)dy =
∫ ∞
−∞
exp
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= 1 Γ(s) =
∫ ∞
0
ts−1 exp(−t) dt
C.6 Supplementary Figures
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Fig. C.1. Comparison of estimates obtained averaged across 50 datasets at a large
per SNP heritability (5e-5). We show results based on a true average polygenicity of 2.5% (a)
and a true average polygenicity of 30% (b). The horizontal black lines correspond to the truth.
Note that the y-axis in each subplot are in different scales.
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Fig. C.2. Estimated bias obtained averaged across 50 datasets as the per SNP
heritability increases (Large effect = 5e-5 vs Small effect = 4e-7). We show results based
on a true average polygenicity of 2.5% (a) and a true average polygenicity of 30% (b). The sample
size, N, when the per SNP heritability is small (4e-7) is inflated by a factor of 64. The horizontal
black lines correspond to the bias at the truth.
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Fig. C.3. Effect of increasing SNP size on estimation at a sample size of 500 when
E(h2g), E(πg), and SD(h
2
g) are fixed. We show results for E(h
2
g), SD(h
2
g), and E(πg) respectively.
Horizontal black lines correspond to the truth. Note that the y-axis in each subplot are in different
scales.
Fig. C.4. Comparison of estimates obtained averaged across 50 datasets at a sample
size of 5,000 when E(h2g), E(πg), and SD(h
2
g) are fixed. Horizontal black lines correspond to
the truth. The plots from left to right are for E(h2g),SD(h
2
g), and E(πg) respectively. Note that the
y-axis in each subplot are in different scales.
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Fig. C.5. Comparison of estimates obtained averaged across 50 datasets at a sample
size of 5,000 as SD(h2g) increases when E(h
2
g), and E(πg) are fixed. Horizontal black
lines correspond to the truth. Values on the y-axis represent estimates obtained from model fit
while values on the x-axis represent SD(h2g). The plots from left to right are for E(h
2
g),and E(πg)
respectively. Note that the y-axis in each subplot are in different scales.
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